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Summary 
 
Phosphoinositides are key lipid signaling molecules present in membranes of all 
eukaryotes. Different species of phosphoinositides serve as membrane signposts at 
distinct cellular compartments. This assymetric distribution of phosphoinositides is 
achieved by the presence of an elaborate set of lipid kinases and phosphatases operating 
at specific organelle membranes. The lipid phosphatase SAC1 is found in both 
endoplasmic reticulum (ER) and Golgi. Similar to yeast Sac1p, human SAC1 (hSAC1) is 
the major phosphatidylinositol-4-phosphatase (PI(4)P-phosphatase). Distinct localization 
of hSAC1 in both ER and Golgi membranes suggests that this PI(4)P-phosphatase has 
compartment specific roles in regulating steady state distribution of PI(4)P in these 
organelles. OCRL1 is a Golgi and endosomal localized PI(4,5)P2 5-phosphatase that is 
implicated in a severe X-linked disease, Lowe syndrome, which is characterized by 
congenital cataracts, Fanconi syndrome and mental retardation. How mutations in 
OCRL1 cause Lowe syndrome is unknown. The functional analysis of hSAC1 and 
OCRL1 in regulating Golgi PI(4)P and PI(4,5)P2 is the main focus of this work. 
Confocal immunofluorescence and immuno-electron microscopy (immuno-EM) 
show that PI(4)P and hSAC1 form an opposing gradient in the Golgi. hSAC1 is highly 
enriched at Golgi cisternal membranes while PI(4)P is concentrated at the trans-Golgi 
network (TGN) where cargo proteins are packaged and exported. Golgi enzymes such as 
N-acetylglucosaminyltransferase I (NacT1) and mannosidase II (ManII) are preferentially 
found in these PI(4)P-depleted areas. siRNA-mediated knock-down of hSAC1 leads to 
accumulation of PI(4)P at Golgi, plasma membrane and endosomal like structures and 
causes mislocalization of ManII and NacT1. This data suggests that SAC1 establishes 
PI(4)P-depleted Golgi regions that are important for proper localization and recycling of 
Golgi resident enzymes. Conversely, depletion of OCRL1 does not disturb Golgi 
morphology or induce mislocalization of Golgi resident enzymes. However, bulk 
secretion is inhibited in OCRL1 depleted cells. The OCRL1-b splice variant populates 
TGN and early endosomal compartment whereas the OCRL1-a splice variant containing 
an extra 8 amino acid acidic cluster is found only in a subset of late endosomal/ 
lysosomal membranes. This distinct localization of OCRL1 splice variants indicates that 
each isoform might regulate different trafficking routes by regulating PI(4,5)P2 levels at 
these compartments.  
 Together, the results show that hSAC1 and OCRL1 establish distinct 
phosphoinositide-specific domains within the Golgi that are instrumental for segregation 
of anterograde trafficking from the recycling of resident Golgi enzymes.  
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Zusammenfassung 
 
Phosphoinositide sind Lipidsignale mit Schlüsselfunktion, die in den Membranen aller 
Eukaryoten vorkommen. Die verschiedenen Klassen von Phosphoinositiden dienen als 
spezifische Wegweiser an den Membranen zellulärer Kompartimente. Die asymmetrische 
Verteilung der Phosphoinositide wird durch ein komplexes Netzwerk von Lipidkinasen 
und –phosphatasen gewährleistet, die jeweils spezifisch an den Organellmembranen 
arbeiten. Die Lipidphosphatase Sac1 befindet sich sowohl im Endoplasmatischen 
Retikulum (ER) als auch im Golgi-Apparat. Konserviert von der Hefe zum Mensch, ist 
Sac1 die wichtigste Phosphatidylinositol 4-Phosphatase (PI(4)P-Phosphatase). Die 
Lokalisation von hSAC1 an ER- und Golgimembranen legt nahe, dass dieses Enzym 
kompartimentspezifische Rollen in der Regulierung der Verteilung von PI(4)P in diesen 
Organellen hat. OCRL1 ist eine PI(4,5)P2 5-Phosphatase am Golgi und in Endosomen. 
Mutationen in OCRL1 verursachen das Lowe Syndrom, eine schwere X-chromosomal 
vererbte Krankheit. Das Lowe-Syndrom zeichnet sich durch congenitale Katarakte, 
schwere Nierenschäden und geistige Behinderung aus. Wie Mutationen in OCRL1 das 
Lowe-Syndrom verursachen, ist unbekannt. Die funktionelle Analyse der Regulierung 
von PI(4)P und PI(4,5)P2 am Golgi durch hSAC1 und OCRL1 ist das Thema dieser 
Arbeit.  
 
Konfocale Immunfluoreszenz und Immuno-Elektronenmikroskopie zeigen, dass PI(4)P 
und hSAC1 entgegengesetze Gradienten im Golgi bilden. hSAC1 ist in den Membranen 
der Golgizisternen angereichert, während PI(4)P im Trans-Golgi-Netzwerk (TGN 
konzentriert ist. Im TGN werden sekretorische Proteine auf dem Transportweg verpackt 
und exportiert, Golgienzyme wie N-Acetylglucosaminyltransferase I (NacT1) und 
Mannosidase II (ManII) befinden sich bevorzugt in Golgiregionen mit geringem PI(4)P 
Gehalt. Depletierung von hSAC1 mittels siRNA führte zur Akkumulierung von PI(4)P im 
Golgi, an der Plasmamembran und in endosmalen Strukturen und führte zur 
Mislokalisierung von ManII und NacT1. Dieses Ergebnis legt nahe, dass SAC1 am Golgi 
Regionen mit geringem PI(4)P-Gehalt herstellt, welche für die korrekte Lokalisation und 
das Recycling Golgi-residenter Enzyme wichtig sind. Depletierung von OCRL1 mittels 
RNAi verändert jedoch weder die Morphologie des Golgi, noch führt sie zur 
Mislokalisation Golgi-residenter Enzyme. Allerdings hemmt die Entfernung von OCRL1 
die zelluläre Proteinsekretion. OCRL1 kommt in zwei Spleissvarianten vor: OCRL1-a 
und OCRL1-b. Die OCRL1-b Variante kommt im TGN und in frühen Endosomen vor, 
wohingegen die Variante OCRL1-a, welche zusätzlich ein Sequenzmotif aus 8 
hauptsächlich sauren Aminosäuren enthält, nur in einer bestimmten Population von 
späten Endosomen/ Lysosomen vor. Die spezifische Lokalisation von OCRL1 könnte 
bedeuten, dass die Isoformen jeweils spezifische Transportwege regulieren, indem sie die 
PI(4,5)P2 Level in ihren Kompartimenten anpassen.  
 
Zusammengenommen zeigen diese Resultate, dass hSAC1 und OCRL1 spezifische 
Phosphosinositiddomänen im Golgi herstellen, die für die Trennung von Recycling von 
Golgi-residenten Proteinen und anterogradem Transport von sekretorischen Proteinen 
unerlässlich sind.     
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1 Abbreviations 
 
α         anti/ alpha 
Amp            ampicilin 
APS             amonium persulfate 
aa               amino acid 
ATP            adenosinetriphosphate 
bp               base pair 
CFP             cyan fluorescent protein 
DAG           diacylglycerol 
Da               Dalton 
ddH2O        distilled water 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
DTT  dithiothreitol 
EDTA  ethylendiaminetetracetatic acid   
ER   endoplasmic reticulum 
g   gram 
GalT  galactosyltransferase 
GFP  green fluorescent protein 
hrs   hours 
HEPES  4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid 
HPLC  high performance liquid chromatography 
kb   kilobase 
kDa  kilo Dalton 
L   liter 
LB   Luria Betrani broth 
M   molar 
mM  milimolar 
mA  miliampere 
mg   miligram 
µCi  microcurie 
µl   microliter 
µg   microgram 
µM  micromolar 
min  minute 
ml   mililiter 
nM   nanomolar 
nm   nanometer 
OD  optical density 
ON   overnight  
ONC   overnight culture 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate buffer saline 
PCR  polymerase chain reaction 
PM  plasma membrane 
   
  1 Abbreviations 
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pmol  picomol 
PMSF  phenylmethylsulphonylfluoride 
PtdIns  phosphatidylinositol 
PI   phosphoinositides 
PI(4)P  phosphatidylinositol-4-phosphate 
PtdIns(3)P  Phosphatidylinositol(3)phosphate  
PtdIns(4)P  Phosphatidylinositol(4)phosphate  
PtdIns(5)P  Phosphatidylinositol(5)phosphate  
PtdIns(3,4)P2  Phosphatidylinositol(3,4)bisphosphate  
PtdIns(4,5)P2  Phosphatidylinositol(4,5)bisphosphate  
PtdIns(3,5)P2  Phosphatidylinositol(3,5)bisphosphate  
PtdIns(3,4,5)P3  Phosphatidylinositol(3,4,5)trisphosphate  
RFP   red fluorescent protein  
rpm   revolutions per minute  
RT   room temperature 
s    second  
SAC   suppressor of actin mutants  
SDS   sodium dodecyl sulfate 
TAE   tris/acetate/EDTA  
TCA   2,2,2-trichloracetic acid  
TEMED   N,N,N´,N´-tetramethyldiamine  
TGN   trans-Golgi-network  
Tris   tris(hydroxymethyl)-aminomethane  
Tryp   trypsin  
TX-100   triton-X-100  
Unit   unit of enzyme activity.  
V    volt  
WT   wildtype 
YFP   yellow fluorescent protein  
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2 Introduction 
2.1: Biological roles of phosphoinositides and their modifying enzymes 
 Eukaryotic cells possess an elaborate system of membrane enclosed 
compartments that are characterized by distinct sets of proteins and lipids. Each cellular 
compartment must maintain its unique function, molecular composition, and luminal 
environment. To achieve this diversity of structure and purpose, the membranes of these 
organelles must be kept separate for the most part, else they might rapidly fuse and 
become homogenous. These membrane compartments are, however, interconnected via 
exchange of materials using different transport vesicles or tubular-vesicular carriers 
(Bonifacino and Glick 2004). To achieve successful and specific inter-organellar material 
exchange, recognition of target membranes by transport vesicles is vital. Different classes 
of proteins have been found as main players in the formation of these transport 
vesicles/carriers, but advances in the field of membrane trafficking have recognized the 
active participation of membrane lipids in all transport events. In fact, lipid bilayers, the 
building blocks of all biological membranes contain embedded signals that are composed 
of different classes of  phospholipids. One such important class of lipid-based signals are 
the phosphoinositides (PIs) (Toker 2002) 
 
2.1.1: Phosphoinositides: lipid signaling in eukaryotic membranes 
Phosphoinositides are phosphorylated derivatives of phosphatidylinositol (PtdIns) 
found throughout the eukaryotic kingdom. They are composed of a myo-inositol sugar 
moiety attached to diacylglycerol (DAG) via a phosphodiester bond. The unique property 
of these phospholipids is contributed by the inositol headgroup that can be reversibly 
phosphorylated at different positions (3, 4, 5-OH). The interplay between the kinases and 
phosphatases generates seven different species of phosphoinositides (Tolias and Cantley 
1999; see Figure 2.0). 
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Figure 2.0:(A) Structure of phosphatidylinositol (PtdIns) and its phosphorylated derivatives, 
phosphoinositides (B) 
 
These inositol-containing glycerophospholipids are among the most versatile of 
regulatory molecules, with strikingly diverse roles in cell signaling, membrane transport, 
actin cytoskeleton rearrangement, cell development, cell survival, and transcriptional 
regulation (Toker 2002). Each phosphoinositide species possesses unique functions at 
different cellular compartments. They mark and contribute to membrane identity of 
distinct cellular organelles (Cockcroft and De Matteis 2001; De Matteis and Godi 2004). 
For example, phosphatidylinositol-3-phosphate (PI(3)P) populates the endosomal systems 
(at the early endosomes (EE)), phagosomes (Ph) and the internal vesicles of 
multivesicular bodies (MVB) (Figure 2.1), while the phosphatidylinositol-3,5-
bisphosphate (PI(3,5)P2) is created at the MVBs or late endosomal compartment by the 
presence of the PIK-FYVE kinase. On the other hand,  phosphatidylinositol-4-phosphate 
(PI(4)P) is enriched at the Golgi apparatus while phosphatidylinositol-4,5-bisphosphate 
(PI(4,5)P2) is found predominantly at the plasma membrane. Upon agonist mediated cell 
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stimulation, phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) is transiently produced 
by the PI 3-kinases from PI(4,5)P2 at the D-3 position of the myo-inositol ring. Figure 2.1 
shows the intracellular “phosphoinositides map”. Phosphoinositides (for example 
PI(4,5)P2, PI(4)P and inositol polyphosphates) are also present in the nucleus. However, 
the functions of individual nuclear phosphoinositides are unclear. They have been 
implicated in regulation of gene expression, mRNA export, DNA repair and telomerase 
maintenance (Gonzales and Anderson 2006; York 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Spatially restricted pools of phosphoinositides at different cellular organelles. (Adapted 
from Mayinger P., 2006) 
PI(4)P is highly enriched at the Golgi, PI(4,5)P2 at the plasma membrane and the 3-phosphorylated species 
of phosphoinositides are located at the endosomal systems. 
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2.1.2: Phosphoinositide interacting factors  
Spatially restricted generation of PIs at different organellar membranes serve as 
an ideal platform for the recruitment of distinct signaling complexes (Hurley and Meyer 
2001) . Phosphoinositides orchestrate diverse signaling and cellular events by recruiting 
diverse classes of proteins, containing specific phosphoinositide binding modules, to 
execute their functions (Lemmon 2003).  
The pleckstrin homology domain (PH-domain) was originally identified in 1993 
(Haslam, Koide et al. 1993; Mayer, Ren et al. 1993) as a stretch of 100-120 amino acids 
appearing twice in the platelet protein pleckstrin (Tyers, Rachubinski et al. 1988; Tyers, 
Haslam et al. 1989). PH-domain was initially found to interact with PI(3,4,5)P3 and 
PI(3,4)P2 in a group of proteins that are involved in PI 3-kinase-mediated signaling 
events. Protein kinase B/Akt, 3-phosphoinositide-dependent protein kinase 1 (PKD1) and 
the Bruton’s tyrosine kinase (BTK) are examples of PH-domain containing proteins that 
bind to 3-phosphorylated inositol lipids. In subsequent studies, many PH-domains were 
found to bind a broad class of PIs and other membrane determinants such as the Arf 
GTPases. The abundance of PH-domains in the human genome (approximately 250 PH 
domains in human proteome) suggests that they are important lipid interacting domains 
with diverse functions depending on their binding specificities to different 
phosphoinositides and other membrane determinants(Yu, Mendrola et al. 2004).  
The PH-domain of PLC-δ is targeted to the plasma membrane specifically via 
interaction with PI(4,5)P2. A GFP-fusion protein of PLC-δ’s PH domain can detect only 
the plasma membrane pool of PI(4,5)P2 but not PI(4,5)P2 at the Golgi (Varnai and Balla 
1998). The PH-domain of FAPP1 (phosphatidylinositol-four-phosphate adaptor protein 1) 
was found to bind PI(4)P in earlier studies (Dowler, Currie et al. 2000). However, it has 
been shown recently by Godi A. et al. that the Fapp1-PH domain binds to activated Arf1 
in addition to PI(4)P at the trans-Golgi network (TGN) (Godi, Di Campli et al. 2004) . 
Both membrane determinants (PI(4)P and GTP-bound Arf1) are crucial for proper 
targeting of Fapp1 to TGN. This is an example of a dual-key mechanism for protein 
recruitment to specific membrane compartments (Itoh and De Camilli 2004). Other 
PI(4)P-binding proteins found till date are adaptor protein 1 (AP1) (Wang, Wang et al. 
2003), epsinR, oxysterol binding protein (OSBP) (Levine and Munro 1998), ceramide 
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transfer protein (CERT) (Kumagai, Yasuda et al. 2005) and Fapp2 (Godi, Di Campli et al. 
2004) . Eventhough these proteins are all targeted to the TGN via interaction with PI(4)P, 
with or without GTP-bound Arf1, they operate at distinct transport steps from the TGN. 
Fapp2, OSBP and CERT share two interesting features: N-terminal PH-domains that bind 
to PI(4)P with high affinity and C-terminal lipid-transfer domains with distinctive lipid 
specificities. The lipid-transfer domain of OSBP binds to oxysterol/cholesterol, CERT 
binds ceramide, and FAPP2 binds to glycolipids. These recent findings open new avenues 
in research focusing on non-vesicular lipid transport between organellar membranes 
(Maxfield and Mondal 2006). 
Other phosphoinositide binding modules that operate at different organelles such 
as the endosomes and the plasma membrane include FYVE (Fab1p, YOTB, Vac1p and 
EEA1) (Burd and Emr 1998; Kutateladze, Ogburn et al. 1999) and PX (phox homology) 
domains(Simonsen and Stenmark 2001; Xu, Seet et al. 2001; Seet and Hong 2006) . 
PI(3)P is generated at the endosomal membranes by the class III PI3-kinases, Vps34 
(Herman and Emr 1990) . PI(3)P is found at the membrane of the early endosomes, 
internal vesicles of mutivesicular endosomes in mammals, and vacuolar endosomes in 
yeasts. Most FYVE and PX domains bind to PI(3)P specifically. The FYVE domain was 
first identified in four proteins: Fab1p, YOTB, Vac1p and EEA1. It contains 60-70 amino 
acids and folds into a zinc finger-like structure. FYVE domain binds to PI(3)P-containing 
membranes with very high affinity and requires membrane insertion. EEA1, Hrs, 
Rabenosyn-5 and other proteins operating at the endosomal systems contain the 
membrane targeting FYVE domain. 
The PX domain was discovered in 1996 and is named after the phagocyte oxidase 
that provides a defense against microorganisms (Ponting 1996). PX domain is composed 
of 120 amino acids. The most common ligand for this module is PI(3)P, although some 
PX domains bind to PI(3,4)P2 and PI(4,5)P2 (Xu, Seet et al. 2001). PX domain of Vam7 
was the first to be ascribed a specific recognition of PI(3)P(Cheever, Sato et al. 2001) . 
This protein-lipid interaction is attributed to a pair of highly conserved basic motifs, RRφ 
(Arg-Arg-Tyr/Phe residues). Other PX domain containing proteins that are recruited to 
endosomal membranes include the sorting proteins nexin 3 and Vps5.  
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The Epsin N-terminal Homology (ENTH) domain was originally identified as an 
NH2-terminal sequence of epsin 1 and several other proteins that had known or putative 
roles in endocytosis (Rosenthal, Chen et al. 1999) (Kay, Yamabhai et al. 1999)  . The 
ENTH domains were known to bind to PI(4,5)P2 with high specificity. They are present 
in Epsin, AP180 and CALM (Clathrin Assembly Lymphoid Myeloid leukemia) proteins. 
These ENTH domains undergrid the invaginating plasma membrane through PI(4,5)P2 
interactions, and the clathrin coat connects to this scaffold. Recent structural data shows 
that proteins related to AP180 and CALM have an N-terminal domain with a distinct fold. 
This domain is named the ANTH domain (AP180 N-terminal Homology domain). Both 
domains bind PI(4,5)P2 via different binding modes (Ford, Mills et al. 2002) (Ford, 
Pearse et al. 2001) Proteins that contain ENTH/ANTH domains are found to contain 
other recognition motifs for other types of protein-protein interaction modules. This is 
particularly important for assembly of protein complexes on membranes. 
 
2.1.3: Organelle identity and membrane signposts defined by phosphoinositides    
Distinct sets of enzymatic activities at different intracellular locations define the 
“functional identity” of  each intracellular organelle. Recent progress in studying 
mechanisms of intracellular transport systems has defined a new concept explaining 
organelle membrane identity based on the presence of specific peripheral membrane 
proteins (membrane traffic machinery), activated forms of GTPases (including the GTP-
exchange factors (GEF) and GTPase-activating proteins (GAP)), and lipids (Munro 2002; 
Munro 2004; Behnia and Munro 2005).   
Although phosphoinositides are minor constituents of membrane lipids (typically 
10% of the total membrane lipids in cellular membranes), phosphoinositides are a 
particularly important class of lipids that contribute to organelle identity. They are short-
lived lipid signposts that direct effector proteins to specific membrane sites where cellular 
functions are carried out. Organelle identity is crucial for accurate recognition of 
transport vesicles traveling from one cellular compartment to another.  
As illustrated in Figure 2.1, the membrane signposts expressed by individual 
cellular compartments are critical for a functional secretory pathway. The endoplasmic 
reticulum (ER) is the site of synthesis for phosphatidylinositol (the precursor of other 
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phosphoinositides) and there are no known or observed phosphoinositide species that 
accummulate at this compartment. However, all the other cellular compartments 
throughout the secretory pathway contain specific sets of phosphoinositides functioning 
in recognition of transport machineries that carry cargos to their final destinations. Figure 
2.2 shows examples of phosphoinositide binding module (PIBM)-containing proteins 
(Overduin, Cheever et al. 2001).  
 
Figure 2.2: Phosphoinositide binding modules in effector proteins  
Signaling domains that have been demonstrated to bind phosphoinositides are shown as colored shapes 
with schematic binding site. Arrows indicate the preferred ligand of the given signaling domain, and 
proteins that contain the given signaling domain are listed in corresponding colored shape. (Adapted from 
Overduin et al., 2001)  
 
The importance of organelle membrane identity is further demonstrated by 
subversion of  “original” membrane identity by various pathogenic organisms (Nguyen 
and Pieters 2005) such as Salmonella, Listeria, Mycobacterim tuberculosis and Shigella. 
These pathogens use their own secretion systems to transfer virulence factors into host 
cells for perturbations of membrane identity. Membrane transport and fusion events are 
particularly affected in this matter since proper trafficking and fusion reactions require 
recognitions of the right donor and acceptor membrane compartments. 
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2.1.4: Compartmentalized distribution of phosphoinositides generated by 
phosphoinositide kinases and phosphatases 
To achieve differential distribution of phosphoinositides at intracellular 
membranes, every organelle is equipped with an array of phosphoinositide kinases and 
phosphatases (De Matteis and Godi 2004) as shown in Figure 2.3 
 
 
Figure 2.3: Phosphoinositide kinases and phosphatases and their intracellular localization 
The phosphorylation/dephosphorylation cycles of phosphoinositides are catalyzed by distinct classes of 
phosphoinositide kinases and phosphatases. The reactions catalyzed by the kinases are in black arrows 
while the grey arrows indicate the phosphatase activities. Abbreviations: GC, Golgi complex; PM, plasma 
membrane; ER, endoplasmic reticulum; N, nucleus; E, endosomes; LE, late endosomes; Ly, lysosomes; SV, 
synaptic vesicles; CCV, clathrin-coated vesicles; Mi, mitochondria; ND, not determine.(Adapted from De 
Matteis M.A. and Godi A., 2004) 
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2.1.4.1: Phosphoinositide 3-kinases (PI 3-kinases) 
The phosphoinositide kinases have been subjects of intensive studies due to their 
pivatol role in generating lipid signals. The phosphoinositide 3-kinases (PI 3-kinases) and 
its lipid products have been at the central stage of research interests due to their functions 
in cell proliferation, migration and transformation (Leevers, Vanhaesebroeck et al. 1999) . 
The PI 3-kinases are classified into three different classes based on their domain 
structures, catalytic activities and modes of regulation (Fruman, Meyers et al. 1998). The 
class I PI 3-kinases are further subclassified into classes IA and IB with regard to their 
distinct regulatory subunits (50-85kD for class IA; p101 for class IB) and isotypes of  
p110 catalytic subunits (p110α, p110β and p110δ). The main product of class I PI 3-
kinases is PI(3,4,5)P3 although they are capable of phosphorylating PtdIns, PI(4)P and 
PI(4,5)P2. PI(3,4,5)P3 is an important signal for cell proliferation and survival. 
 The class II PI 3-kinases (α, β and γ) are larger proteins that catalyze the 
phosphorylation of PtdIns and PI(4)P (but not PI(4,5)P2) in vitro. Their C2 domain can 
interact with phospholipid substrate in a calcium dependent manner (Rizo and Sudhof, 
1998). The PI3KIIα and PI3KIIγ have been shown to be associated with the Golgi 
complex (Ono, Nakagawa et al. 1998; Gaidarov, Smith et al. 2001; Kihara, Kabeya et al. 
2001). The PI3KIIα binds clathrin. Overexpression of this kinase induces the 
redistribution of the mannose 6-phosphate receptor (M6PR) from the TGN to the cell 
periphery and inhibits endocytosis (Gaidarov, Smith et al. 2001)  
The class III PI 3-kinases can only catalyze the phosphorylation of PtdIns to 
PI(3)P. In yeast, there is only one PI 3-kinase, Vps34, which belongs to class III. All 
eukaryotes investigated so far have a Vps34p homologue. Recruitment of Vps34p to 
cellular membranes is mediated by interaction with a serine/threonine kinase, Vps15p 
(Stack, Herman et al. 1993; Stack, DeWald et al. 1995). 
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2.1.4.2: Phosphoinositide 4-kinases (PI 4-kinases) 
The formation of PI(4)P is catalyzed by phosphatidylinositol 4-kinases using 
PtdIns as precursor (Balla and Balla 2006). PI(4)P was initially known as the precursor 
for the generation of PI(4,5)P2 and PI(3,4,5)P3. Only very recently, PI(4)P is recognized 
to be a unique lipid signal that regulates many cellular processes such as anterograde 
traffic from the Golgi (Hama, Schnieders et al. 1999; Schorr, Then et al. 2001).  
There are 4 distinct classes of PI 4-kinases in mammals while yeasts possess three 
PI 4-kinases. In general, the PI 4-kinases are classified into type II and type III based on 
their biochemical properties. The mammalian type II PI 4-kinases are the PI4KIIα and 
PI4KIIβ. Yeast has only a type II PI 4-kinase, Lsb6p (Han, Audhya et al. 2002; Shelton, 
Barylko et al. 2003). Lsb6p is a non-essential gene and contributes for a minor fraction of 
total PI 4-kinase activity in yeast. The PI4KIIα is tightly associated with membranes and 
found at the Golgi and endocytic compartment while PI4KIIβ is mostly cytosolic and  is 
recruited to the plasma membrane where it is activated by Rac1 (Wei, Sun et al. 2002).  
Two isoforms of type III PI 4-kinases have been cloned in mammals: the 
PI4KIIIα and its yeast homologue Stt4p(Yoshida, Ohya et al. 1994) ; the PI4KIIIβ and its 
homologue, Pik1p in yeast. PI4KIIIα has been found at the plasma membrane and ER 
(Wong, Meyers dd et al. 1997) while the PI4KIIIβ has been localized to the Golgi 
complex (Godi, Pertile et al. 1999). However, yeast Pik1p has been found in the nucleus 
besides its Golgi localization. The PI4KIIIβ and PI4KIIα are among the best studied 
PI4Ks in mammals. Both kinases are important in generating different pools of  PI(4)P at 
the Golgi to recruit different adaptor proteins for anterograde trafficking (Wang, Wang et 
al. 2003; Godi, Di Campli et al. 2004). Both Pik1p and Stt4p are essential genes in yeast.  
Pik1p has similar functions to PI4KIIIβ at the Golgi ( it generates PI(4)P pools that are 
important in forward trafficking, and maintenance of Golgi structure) while Stt4p 
regulates different pools of PI(4)P at the plasma membrane (for regulation of actin 
cytoskeleton and cell wall integrity) (Audhya, Foti et al. 2000)  
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2.1.4.3: Phosphatidylinositol-phosphate Kinases (PIP-kinases) 
 The phosphatidylinositol-phosphate kinases utilize single or double-
phosphorylated inositol lipids as substrates. There are PIP 5-kinases and PIP 4-kinases 
which function in different paths of membrane trafficking. 
The PIP 5-kinases were originally purified as activities that generate PI(4,5)P2 
from PI(4)P. Based on sequence homology, the PIP5-kinases are grouped into type I and 
type II. The Type II kinases phosphorylate the D-4 but not D-5 position. Thus, PIP 5-
kinase II proteins are PIP 4-kinases. However, both group of  kinases do phosphorylate 
the D-3 position of the inositol head group. There are three human PIP 5-kinases 
(PIP5KIα, PIP5KIβ and PIP5KIγ) while budding yeast has Mss4p and Fab1p. Mss4p is 
localized to the plasma membrane where it plays a role in making PI(4,5)P2 from PI(4)P 
(Homma, Terui et al. 1998). Mss4p contains a nuclear localization signal. It is activated 
at the plasma membrane through a regulated transport between the nucleus and the 
plasma membrane(Audhya and Emr 2003). The mouse ortholog of Fab1p is PIK-fyve. 
Both enzymes are important in generating PI(3,5)P2 from PI(3)P and operate in 
endosomal systems (Gary, Wurmser et al. 1998; Odorizzi, Babst et al. 1998).  
 
2.1.4.4: Phosphoinositide phosphatases 
The consumption of phosphoinositides (signal termination) by different classes of 
phosphatases is critical for membrane homeostasis and cell physiology as testified by 
various human disease that are caused by mutations in different PI-phosphatases 
(Pendaries, Tronchere et al. 2003).  
 
2.1.4.4.1: Phosphoinositide 3-phosphatases (PI 3-phosphatases) 
The PI 3-phosphatases consist of phosphatase and tensin homolog deleted on 
chromosome ten (PTEN), TPIP, myotubularin (MTM) and myotubularin-related proteins 
(MTMRs). PTEN is one of the most studied PI-phosphatases till date. Other names given 
to this phosphatase include MMAC1 (mutated in multiple advanced cancers 1) and TEP1 
(transforming growth factor β-regulated and epithelial cell-enriched phosphatase). PTEN 
was first identified as a tumor-suppressor gene located at chromosome 10q23.3, where 
mutations in this region caused high-grade glioblastomas, prostate and breast cancers (Li, 
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Yen et al. 1997). PTEN is a dual-specificity phosphatase towards protein substrates and 
phosphoinositides. Its tumor suppressor role is due to its ability to down-regulated 
Akt/PKB mediated cell proliferation and cell survival signals mediated by PI(3,4,5)P3 
(Maehama and Dixon 1998; Cantley and Neel 1999). PTEN is localized to the plasma 
membrane. This localization is controlled by multiple phosphorylation sites of PTEN at 
its C-terminus. The PTEN homologue in yeast, Tep1p was found to link phosphoinositide 
signaling and sporulation (Heymont, Berenfeld et al. 2000). However, a recent study 
showed that Tep1p has no PI(3)P 3-phosphatase activity in vivo (Rodriguez-Escudero, 
Roelants et al. 2005). 
 The MTM and MTMRs are PI 3-phosphatases that dephosphorylate PI(3)P and PI(3,5)P2. 
Mutations in this class of phosphatases have been linked to human diseases such as 
myotubular myopathy and Charcot-Marie-Tooth syndrome (Blondeau, Laporte et al. 
2000; Taylor, Maehama et al. 2000; Azzedine, Bolino et al. 2003). Ymr1p is the yeast 
homologue of MTM. Ymr1p plays an important role in the endocytic compartment in 
functions such as vacuolar protein sorting and maintenance of a functional endosomal 
system (Parrish, Stefan et al. 2004). 
 
2.1.4.4.2: Inositol polyphosphate 5-phosphatases 
 The inositol polyphosphate 5-phosphatases comprise a large family of proteins 
that hydrolyze the 5-phosphate from the inositol ring of both the inositol phosphates and 
/or the PIs. They are classified into type I and type II 5-phosphatases according to their 
enzymatic activities. Only the type II 5-phosphatases can hydrolyze phosphatidylinositol 
phosphates. The type II phosphatases have an additional type II phosphatase domain. The 
existence of additional regulatory domains in type II 5-phosphatases is used to further 
classify them into SHIPs (SH2 domain-containing inositol 5-phosphatases) and GIPs 
(GAP domain-containing inositol 5-phosphatases) (Hughes, Cooke et al. 2000). SHIP1 
and SHIP2 are examples of the SHIPs that can dephosphorylate PI(3,4,5)P3 to PI(3,4)P2 
by removing the 5-phosphate. Mutations in SHIP1 have been shown to contribute to the 
development of acute leukemia and chemotheraphy resistance. On the other hand, SHIP2 
is linked to type 2 diabetes and obesity (Dyson, Kong et al. 2005). OCRL1 is an example 
of GIPs and will be discussed in detail in Section 2.3.4.3.  
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2.1.4.4.3: SAC domain-containing phosphatases 
The SAC domain-containing phosphatases were the first identified in yeast (Guo, 
Stolz et al. 1999). The founding member of  SAC domain phosphatases, Sac1p, was 
found initially as a suppressor of actin mutation, act1-1ts (Cleves, Novick et al. 1989) 
(Novick, Osmond et al. 1989)giving rise to the name of the phosphatase. It was found 
that mutations in SAC1 could bypass the cellular requirement for the yeast 
phosphatidylinositol/phosphatidylcholine transfer protein, SEC14p (Cleves, Novick et al. 
1989). 
 
 
Figure 2.4: Members of the SAC domain-containing family of phosphatases.  
The SAC domain is found in two classes of protein: the SAC domain-containing phosphatidylinositol 
phosphate 5-phosphatase (SCIPs) such as human synaptojanins and the related yeast proteins Inp51p, 
Inp52p and Inp53p. The SCIPs contained a type II 5-phosphatase domain and a proline-rich region at the 
C-terminus. The second class of SAC domain-containing phosphatases are represent by yeast Sac1p and 
Fig4p and human hSAC1(KIAA0851), hSAC2(KIAA0966) and hSAC3(KIAA0274).(Adapted from 
Hughes W.E. et al., 2000) 
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The SAC domain is a 400 amino acid region that exhibits phosphatidylinositol 
polyphosphate phosphatase activity. It contains a highly concerved CX5R(T/S) motif 
which is also present in many metal-independent protein and inositide polyphosphate 
phosphatases. The phosphatase signature motif CX5R(T/S) was first identified in protein 
tyrosine phosphatase (PTP) (Maehama, Taylor et al. 2000). Both PTEN and MTM1-
family of inositol-phosphate phosphatases were initially classified as PTPs due to the 
presence of this motif although their preferred substrates are phosphoinositides. 
The first indication of a phosphatase activity associated with the SAC domain was 
found during work characterizing inhibitors of mammalian PI(4,5)P2-dependent 
phospholipase D (PLD). Synaptojanin was identified as one of the other proteins able to 
inhibit the activity of PLD. This is attributed to the 5-phosphatase catalytic activity of 
synaptojanin that hydrolyzes PI(4,5)P2 required for PLD activity (Chung, Sekiya et al. 
1997). Further study carried out by Guo et al. revealed that the Inp52p and Inp53p of 
yeast synaptojanin homologues also pocess a second phosphatase activity that is 
contributed by the SAC-domain (Guo, Stolz et al. 1999). The SAC-domain was found to 
exhibit a broader-specificity towards PI(3)P, PI(4)P and PI(3,5)P2. However, PI(3,4)P2, 
PI(4,5)P2 and phosphoinositide species with adjacent phosphate groups are not substrates 
of the Sac phosphatase domain.  
As shown in Figure 2.4, the SAC domain phosphatases fall into two main classes 
(Hughes, Cooke et al. 2000). The first category contains the SAC domain-containing 
phosphatidylinositol phosphate 5-phosphatases (SCIPs), that include synaptojanin, sjl1, 
sjl2 and sjl3 (Inp51p, Inp52p and Inp53p) (discuss in Section 2.1.4.4.4). The second 
category of SAC domain-containing phosphatases consists of proteins with an N-terminal 
SAC domain with no other recognizable domains. Sac1p and Fig4p in yeast and the 
mammalian SAC1 phosphatases (rSAC1, hSAC1, hSAC2 and hSAC3) are members of 
this phosphatase family. 
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2.1.4.4.4: SAC domain-containing inositol 5-phosphatases (SCIPs) 
The type II 5-phosphatases that contain an N-terminal SAC domain are 
designated as SCIPs (SAC domain-containing inositol 5-phosphatases). Synaptojanins 
and their yeast homologues, Inp51p, Inp52p and Inp53p, are members of the SCIPs. 
Synaptojanin 1 is one of the most studied SCIPs in mammals and its function in synaptic 
vesicle recycling is well established ((McPherson, Garcia et al. 1996; Cremona and De 
Camilli 2001). Synaptojanin 1 plays important roles in clathrin-mediated endocytosis of 
synaptic vesicles by regulating the PI(4,5)P2 levels at these specialized cells. It contains 3 
main domains: the N-terminal SAC phosphatase domain, the 5-phosphatase domain and a 
C-terminal proline-riched domain. The proline-riched domain is proposed to be a 
targeting domain for synaptojanin 1 via protein-protein interactions. Synaptojanin 1 
knockout mice have elevated cellular PI(4,5)P2 levels and show accumulation of clathrin 
coated vesicles. Synaptojanin 2 was cloned shortly after the discovery of synaptojanin 1 
as a presynaptic inositol-5-phosphatase (Nemoto Y. et al., 1997). Synaptojanin 2 shows 
ubiquitous expression and is localized differently from synaptojanin 1. Synaptojanin 2 
appears to function at an earlier step in clathrin-mediated endocytosis (Kiss et al., 2002; 
Rusk et al. 2003). 
SCIPs are also found in Saccharomyces cerevisiae where they are considered 
functional homologs of mammalian synaptojanins. They are therefore named Sjl1, Sjl2 
and Sjl3 or Inp51p, Inp52p and Inp53p. Deletion of all three yeast synaptojanin like 
proteins causes lethality. This lethality is a consequence of a dramatic increase of 
PI(4,5)P2 levels (Stefan, Audhya et al. 2002). The other observed phenotypes in Sjl 
knockouts are defective actin cytoskeleton, endocytosis and protein sorting from the 
Golgi to the vacuole. The yeast synaptojanins had also been found to be important in 
cellular events that require clathrin and  have been shown to interact genetically with 
clathrin (Bensen, Costaguta et al. 2000). 
The other members of SAC domain-containing proteins are Fig4p and Sac1p 
which contain only the N-terminal SAC domain without the 5-phosphatase domain 
(Figure 2.4). Fig4p was identified in a screen for pheromone-induced genes (FIG) 
(Erdman, Lin et al. 1998). The SAC domain of Fig4p is not able to complement a Sac1p 
deficiency. Steady state phosphoinositide levels of a ∆fig4p yeast mutant are comparable 
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to wild type yeast (Gary, Sato et al. 2002). Fig4p has no transmembrane domain and its 
recruitment to the vacuolar membrane needs assistance from other proteins (Rudge, 
Anderson et al. 2004). Fig4p is found to be a PI(3,5)P2 specific phosphatase in vitro and 
regulates the MVB-associated PI(3,5)P2 made by the Fab1p PI(3)P 5-kinase (Rudge, 
Anderson et al. 2004). Fig4p orthologues in human have been found but the functions of 
this phosphatase in mammals are unknown (Erdman, Lin et al. 1998). The yeast Sac1p 
and the mammalian SAC1 phosphatases will be discussed in Section 2.3.4.1 and Section 
2.3.4.2. 
 
2.2: Phosphoinositides and membrane trafficking 
Over the last 2 decades, we have witnessed tremendous advances in identification 
of the molecular machinery that drives and controls the inter-organellar transport of 
proteins and lipids. However, the transport machinery that had been characterized and 
studied mainly consisted of protein factors. Membrane lipids were thought to be passive 
components of biological membranes and subjected to deformation by the action of coat 
proteins and small GTPases. The importance of membrane lipid composition in the 
formation and consumption of transport vesicles has only been recognized recently. 
Phosphatidic acid (PtdOH), diacylglycerol (DAG) and phosphoinositides (PIs) are found 
to be essential for vesicular transport (Simonsen, Wurmser et al. 2001) (Odorizzi, Babst 
et al. 2000).  
The ER is the only organelle found so far that is devoid of any phosphoinositide 
species at steady state. The function of inositol lipids in this compartment is unclear. 
However, there is evidence that accumulation of PI(4)P at the ER negatively regulates its 
cellular functions (Kochendorfer, Then et al. 1999; Konrad, Schlecker et al. 2002). A 
very recent finding shows that eEF1A is a direct activator of PI4KIIIβ (Jeganathan and 
Lee 2006). Ectopic expression of eEF1A2 increases activity of PI4KIIIβ and cellular 
PI(4)P abundance. 
The 3-phosphorylated inositol lipids was found to play important roles in 
regulating membrane trafficking and protein sorting at the endosomal and vacuolar 
compartments . Emr and colleagues have demonstrated that Vps34p (a PI 3-kinase) is 
required for normal and efficient routing of proteins from the Golgi to the vacuole (Schu, 
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1993). Vps34p is recruited to the Golgi and is activated by the Vps15p kinase (Stack, 
Herman et al. 1993). This Vps34/Vps150 complex is conserved from yeast to human 
since studies with human version of Vps34 recapitulate this activation circuit (Panaretao 
C. et al. 1997). The functionally conserved Vps34 PI 3-kinase generates pools of  PI(3)P  
which serve as spatial cue for recruitment of effector proteins for TGN-endosomal sorting. 
PI(3,5)P2 is another lipid signal found at the multivesicular bodies (MVB). It is generated 
via the sequential actions of PI 3-kinase and the PI(3)P 5-kinase. In yeast, Fab1p (the 
only PI(3)P 5-kinase) is recruited to the endosomal membranes via its FYVE domain 
through specific binding to PI(3)P. Fab1p is not an essential gene in S.cerevisiae, 
however deletion of this gene causes abnormal vacuolar sorting and morphology (Gary, 
Wurmser et al. 1998) (Odorizzi, Babst et al. 1998). Thus, PI(3,5)P2 regulates the 
internalization of endosomal multivesicular bodies into the vacuole lumen for subsequent 
degradation. Furthermore, the synthesis of  PI(3,5)P2 is accelerated  during osmotic stress 
(Dove, Cooke et al. 1997). Taken together, PI(3,5)P2 may generally function in regulating 
lysosomal homeostasis and in formation of specialized MVBs involved in antigenic 
processing and presentation (Katzmann, Odorizzi et al. 2002; Gillooly, Raiborg et al. 
2003). 
PI(4,5)P2’s functions in regulating membrane trafficking (Martin 2001) were first 
shown in reconstituted regulated dense core granules in permeabilized neuroendocrine 
cells by Martin and colleagues (Hay and Martin 1993; Hay, Fisette et al. 1995) They 
found that phosphatidylinositol transfer protein (PITP) synergizes with a PI(4)P-5 kinase 
in ATP-dependent dense core granules in regulated exocytosis. Other studies show that a 
resident granule PI 4-kinase is essential for stimulated secretion (Wiedemann, Schafer et 
al. 1998). The granule associated with the PI(4,5)P2 pool was shown to be important in 
recruiting protein effectors that regulate the subsequent Ca2+-dependent fusion of dense 
core granules to the plasma membrane. The effector protein that was identified, called 
CAPS (calcium-dependent activator protein for secretion), bound to PI(4,5)P2  via its PH 
domain. Other effector proteins that are recruited by PI(4,5)P2 and involved in regulated 
seretory pathway include synaptotagmin and rabphilin. However, binding of these 
proteins to PI(4,5)P2 is via their C2 domains in the presence of Ca2+. PI(4,5)P2 function in 
the endocytic pathway is established in clathrin-mediated endocytosis which involves 
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adaptor protein AP-2 in clathrin coat assembly in a PI(4,5)P2 dependent manner (Jost, 
Simpson et al. 1998; Gaidarov and Keen 1999).The GTPase, dynamin, is recruited by 
PI(4,5)P2 for scission of clathrin-coated vesicles. PI(4,5)P2 also plays essential roles in 
modulating channel function such as the TRP channel family (Hilgemann, Feng et al. 
2001). 
Besides the plasma membrane, a minor pool of PI(4,5)P2 was shown to reside at 
the Golgi complex and play a role in secretion. The Golgi localized phospholipase D 
(PLD) which hydrolyzes phosphatidylcholine (PtdCho) to phosphatidic acid (PtdOH) and 
choline has been implicated in mammalian Golgi function. PI(4,5)P2  is required for 
efficient catalytic activity of PLD. However, the small GTPase Arf was also shown to 
stimulate the activity of PLD. PtdOH which is generated by PLD from PtdCho activates 
PI(4)P 5-kinase. An interesting study which linked Arf and the generation of Golgi 
PI(4,5)P2 was performed by the laboratory of De Matteis (Godi, Pertile et al. 1999).  Arf 
stimulates a PLD-dependent synthesis of PI(4,5)P2 on Golgi membranes by recruiting a 
specific PI 4-kinase (Pik1β).  
PI(4)P has been long known to be the precursor for synthesis of  PI(4,5)P2 
catalyzed by the type I PIP 5-kinases (Section 2.1.4.3). However, PI(4)P has emerged as 
important signaling molecule at the Golgi complex and in the nucleus. PI(4)P in the 
nucleus functions as precursor of nuclear PI(4,5)P2 while nuclear PI(4,5)P2 is further 
metabolized by a nuclear localized PLC to generate different inositol polyphosphates via 
the inositol polyphosphate kinases (IPKs) and the inositol pyrophosphate synthases 
(IPSs). The function of PI(4)P at the Golgi will be discussed in Section 2.3.3.  
 
2.3: Biogenesis of the Golgi apparatus 
The Golgi apparatus was first described by Camelio Golgi in 1898 when he 
investigated the structure of nerve cells of the spinal ganglia (Golgi 1898) . However, the 
existence of this organelle was doubted for more than 50 years until additional pieces of 
data were obtained using the new techniques at that time, such as electron microscopy 
(EM). The hallmarks of the Golgi apparatus as observed in a thin-sectioned cell under 
EM appeared as a set of flattened, closed membranes (cisternae) which are stacked one 
upon the other. The cisternae were found to be in close proximity to the nucleus.  
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Besides morphological observations of the Golgi apparatus, the Palade’s lab had 
performed pulse-chased experiments using radioactive amino acids such as  [3H]leucine, 
autoradiography and electron microscopy in pancreatic exocrine cells (Jamieson and 
Palade 1967). These experiements shed light in defining the existence of the Golgi 
complex and confirmed its functions at the secretory pathway. In fact, the Golgi complex 
is the heart of the secretory pathway and plays essential roles in modifying lipids and 
proteins that are made in the endoplasmic reticulum.  
Following the huge controversy about the existence of the Golgi apparatus, cell 
biologists are currently having fierceful debates about how this organelle functions within 
the secretory pathway, and whether it is an autonomous organelle or dependent on 
membranes from the ER. It is still under debate which model(s) is/are describing best 
how intra-Golgi transport is achieved (Orci, Amherdt et al. 2000 ; Marsh and Howell 
2002). 
The cisternae maturation/progression model and the vesicular transport/stable 
compartment model are two major important hypotheses that have been proposed. Both 
models start from a common base where the newly synthesized proteins and lipids are 
packaged in COPII vesicles for transport out of the ER. Vesicles and tubules (Vesicular 
tubular cluster) are generated from the COPII budding events at the ER in both models. 
The vesicular transport model proposed that the Golgi complex is a stationary, stable 
compartment. The vesicles are the dynamic elements that are used to transport cargo 
between the static Golgi cisternae. In contrast, each Golgi membrane/cisternae functions 
as bulk carrier for cargo transport across the organelle in the cisternae maturation model. 
New cisternae are formed with each round of cargo transport. The cis or entry cisternae 
are formed by ATP-dependent fusion of vesicles and tubules derived from the 
endoplasmic reticulum (which then form the VTC). The maturation of each cisternae is 
accomplished by addition of the Golgi proteins via retrograde vesicles. The cis cisternae 
becomes medial and finally trans following a progressive series of maturation steps.  
Most recently, a percolating vesicle model, a combination of both cisternae 
maturation and vesicular transport models was suggested (Orci, Ravazzola et al. 2000; 
Pelham and Rothman 2000). Based on this model, there are two populations of COPI 
vesicles. One COPI vesicle population would mediate the fast transport of anterograde 
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cargo between all cisternae in a bi-directional random walk as suggested by the even 
distribution of GS28 over the Golgi apparatus (Orci, Stamnes et al. 1997; Orci, Ravazzola 
et al. 2000). Directional transport is achieved due to the steady state entry of biosynthetic 
cargo at the cis-Golgi and its exit at the trans-Golgi. . The second population of COPI 
vesicles mediate the recycling of enzymes and materials back to ER. The percolating 
vesicle model also integrates a slow anterograde  transport pathway mediated by cisternae 
progression/maturation that accounts for cargo that are too large for COPI vesicles and 
explains the different transport rates observed. 
The continuity-based model was suggested very recently based on electron 
tomography studies. A cargo induced effect on the formation of tubular inter-cisternae 
connections was reported in these studies (Mironov, Beznoussenko et al. 2001; Marsh 
2005). The continuity-based model suggests that transport of cargo is mediated through 
polymorphic carriers that have the ability to bridge adjacent cisternae in a process 
resembling ER-Golgi intermediate compartment (ERGIC) to cis-Golgi cargo transport. 
Cisternae maintenance including Golgi enzyme recycling are accomplished by tubules 
that would only connect subsequent cisternae. The roles of COPI vesicles would solely be 
the control of inter-cisternal fusion events via active uptake of SNARE proteins into 
COPI vesicles and the establishment of Golgi morphology.  
However, regardless of which models that were described above, COPI retrograde 
transport plays a role in maintaining Golgi homeostasis and recycling of Golgi resident 
enzymes. 
 
2.3.1: Mechanisms of Golgi enzyme subcompartmentalisation 
The Golgi complex is not only the hub of the secretory pathway but it bears the 
most vital role in protein and lipid modifications. These post-translational modifications 
are important in modulating the functions and stability of proteins and lipids before they 
are delivered to their final destinations within or outside of the cell. Glycosylation, the 
most common and complex form of post-translational modification is performed by a set 
of glycosyltransferases that are positioned among the Golgi cisternae in a defined manner. 
The relative positions of glycosyltransferases are important in governing the structure and 
repertoire of the sugar branches that are expressed on the cell surface. The large diversity 
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of carbohydrate structures is produced by over 200 different glycosyltransferases situated 
within the individual Golgi stacks. These carbohydrates play an important role in cell-cell 
communication and development of multicellular organisms. This is exampified by a 
large number of human diseases linked to mutations in glycosylenzymes (Freeze 2006; 
Ohtsubo and Marth 2006). 
The membrane-bound glycosyltransferases are the main Golgi resident proteins 
that function for O-linked and N-linked glycosylations. Many of them have been cloned 
and sequenced. They share little amino acid sequence similarity. However, they are all 
type II transmembrane proteins and share a common domain strcuture. They pocess a 
single hydrophobic (single anchor) domain, a luminal stem region and a large C-terminal 
catalytic domain.  
One of the more challenging questions in cell biology is that how Golgi resident 
glycosyltranferases are localized and distributed throughout the Golgi cisternae in a 
highly organized manner. In view of a massive flow of proteins and lipids passing 
through the Golgi complex from the ER, it is unclear how modification, retention and 
secretion happens within the Golgi at such amazing rates and with high precision. Clearly, 
sorting and retention of resident Golgi proteins are important for the maintenance of a 
functional Golgi. 
Mechanisms to localize a distinct set of glycosyl-enzymes in Golgi cisternae have 
been studied extensively and there are few hypotheses/models proposed from studies in 
different laboratories. The initial studies were focused on identification of a targeting 
signal responsible for the localization of several integral membrane proteins to the Golgi 
stacks. A common strategy used was to analyze the localization of hybrid molecules 
containing limited sequences derived from Golgi glycosyltransferases or viral 
glycoproteins known to be specifically retained in the Golgi complex. Localization of 
these fusion proteins revealed that sequences within the transmembrane domains can 
specify Golgi localization (Munro 1991; Nilsson, Lucocq et al. 1991; Swift and 
Machamer 1991; Aoki, Lee et al. 1992; Tang, Wong et al. 1992; Teasdale, D'Agostaro et 
al. 1992; Wong, Low et al. 1992). Munro S., and Colley et al. have also found that 
sequences flanking the transmembrane domain play an auxiliary role in mediating Golgi 
localization. Collectively, these data suggest that the transmembrane domain plays a 
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central role in the targeting and localization of resident Golgi proteins.  In contrast, a 
number of studies have shown that alterations at the transmembrane domain can be made 
without abolishing Golgi retention (Munro 1991; Colley, Lee et al. 1992). Study from 
Burket J. et al. has demonstrated that all three domains of N-
acetylglucosaminyltransferase I contribute to its medial Golgi retention (Burke, Pettitt et 
al. 1992; Burke, Pettitt et al. 1994).  
It has been proposed that retention of resident Golgi proteins involves protein 
oligomerization within the environment of the Golgi compartment (Machamer 1991; 
Nilsson, Lucocq et al. 1991). This is based on a finding that the glycosyltransferases exist 
predominantly as high molecular weight aggregates after detergent extraction (Bendiak 
and Schachter 1987). Experiments carried out by Weisz et al., and Nilsson et al. further 
support the idea of aggregation model of Golgi retention (Nilsson, Pypaert et al. 1993; 
Weisz, Swift et al. 1993).  
 The aggregation model and membrane thickness model (selective partitioning of 
Golgi enzymes into Golgi cisternae based on the thickness of the membrane which is 
equivalent to the length of the transmembrane domain of the protein) are models based on 
a static Golgi (vesicular transport model). In contrast, the cisternae maturation model 
would predict that the Golgi resident enzymes traveled backward via COPI vesicles. In 
this scenario, COPI vesicles should be enriched for Golgi resident enzymes while cargos 
remain in the cisternae which are the main anterograde carriers. Localization of Golgi 
glycosyltransferases requires active partitioning of resident proteins into COPI vesicles 
rather than an anchoring mechanism. Both Klumperman and Nilsson laboratories have 
provided evidence for the concentration of Golgi enzymes in COPI vesicles (Lanoix, 
Ouwendijk et al. 1999; Lanoix, Ouwendijk et al. 2001; Martinez-Menarguez, Prekeris et 
al. 2001). The first group found that the Golgi enzyme mannosidase II is present in COPI 
vesicles with a concentration of 1.5-fold higher than in the cisternae by quantitative 
immuno-electromicroscopy. The Nilsson group showed that COPI vesicles contain Golgi 
enzymes at a concentration that is up to ten times higher than that found in the cisternae. 
 Recent studies using live cell imaging and fluorescent-tagged Golgi proteins 
(including the glycosyltransferases, scaffold, coat proteins and intirant proteins) revealed 
that the Golgi complex is a highly dynamic structure (Ward, Polishchuk et al. 2001). No 
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class of Golgi proteins is stably associated with the Golgi, instead localization of proteins 
at Golgi membranes depends on ongoing traffic between the Golgi and other organelles 
(Bos, Wraight et al. 1993; Reaves, Horn et al. 1993; Ward, Polishchuk et al. 2001). Yet, 
the residency time of different classes of Golgi associated proteins varies enormously. 
While Golgi processing enzymes have long half-lives at the Golgi, cargo proteins and 
cargo receptors spend relatively little time at this organelle (Ward, Polishchuk et al. 2001; 
Presley, Ward et al. 2002). It has therefore been recognized that the Golgi must contain 
functionally and spatially distinct domains that differ by protein and lipid composition. 
Study from laboratory of Wieland provided evidence for a lipid segregation in 
Golgi membranes, as indicated a significant reduction of sphingomyelin and cholesterol 
content in COPI-coated vesicles compared with their donor/parental membranes (Brugger, 
Sandhoff et al. 2000).  
  Another example of the existance of different functional domains at the TGN 
defined by membrane lipids was demonstrated and proposed by Godi A. et al(Godi, Di 
Campli et al. 2004). The recruitment and targeting of the Fapp proteins, OSBP and CERT 
to the Golgi apparatus is dependent on binding of their N-terminal PH-domains to PI(4)P 
and Arf but with distinctive lipid-binding properties that may selectively target them to 
separate TGN domains (Godi, Di Campli et al. 2004). Fapp2 contains a glycolipidtransfer 
domain, OSBP pocesses an oxysterol-binding domain while CERT binds to ceramide via 
its STAR-T domain. This allow generations of different lipid environments where these 
different proteins are bound or recruited.  
 
2.3.2: Phosphoinositides at the Golgi Complex 
As other organellar membranes, the Golgi complex is composed of a unique set of 
proteins and lipids. The Golgi apparatus is a highly polarized organelle where each 
membrane cisterna is occupied by different processing enzymes to modify cargo and 
lipids. The sequence of reactions for protein modification is important to generate 
functionally matured protein or lipid cargo. 
Phosphatidylinositol-4-phosphate (PI(4)P) is concentrated at the Golgi apparatus. 
At steady state, the Golgi can be labeled with PI(4)P-binding probes such as the FAPP1-
PH domain fused with green fluorescence protein. PI(4)P is generated by PI 4-kinases 
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that are recruited to the Golgi membranes. There are two main PI 4-kinases at the Golgi: 
PI4KIIα and PI4KIIIβ. These two kinases are responsible for generating different pools 
of PI(4)P at the Golgi (Weixel, Blumental-Perry et al. 2005) that are recognized by 
different effectors. The PI(4)P pools made by the PI4KIIIβ are regulated by Arf1 through 
activation of this kinase. Besides Arf1, NCS-1 also stimulates the activity of PI4KIIIβ 
(yeast homolog of frequenin). The PI4KIIIβ created PI(4)P recruits the Fapp proteins to 
TGN exit sites(Godi, Di Campli et al. 2004) . Depletion of PI4KIIIβ and the Fapp 
proteins caused accumulation of cargo and formation of long-tubular vesicular structures 
at the TGN. Thus, Fapps are essential elements of a PI(4)P- and Arf-regulated machinery 
that controls the generation of constitutive carriers destined to plasma membrane. The 
Fapp proteins represent members of a superfamily of TGN-associated proteins with a 
common targeting mechanism (based on PI(4)P and Arf1) but with distinctive lipid 
binding properties that may target them to separate TGN domains. 
On the other hand, PI4KIIα creates PI(4)P pools that are important for recruiting 
the adaptor protein 1 (AP1), which functions in clathrin-mediated trafficking 
pathways(Wang, Wang et al. 2003)  Knock-down of this kinase led to inhibition of cargo 
exit out of the Golgi and caused fragmentation of this organelle. However, this defect 
could be rescue by supplying either exogenous PI(4)P or PI(4,5)P2. Recently, PI4KIIα 
has been implicated in regulating the endosomal trafficking and the degradation of the 
EGF receptor (Minogue, Waugh et al. 2006). Inactivation of  PI4KIIα using RNAi or the 
monoclonal antibody 4C5G causes accumulation of ligand-bound EGFR in sub-plasma 
membrane compartment. Furthermore, lysosomal degradation of activated EGFR was 
impaired in PI4KIIα siRNA treated cells. 
In budding yeasts, the function of PI(4)P in anterograde trafficking has been 
demonstrated in cells lacking the Golgi localized Pik1p. S. cerevisiae has only three PI 4-
kinases and each localizes to different cellular compartments. Stt4p localizes to ER and 
PM while Pik1p is found  at the Golgi and the nucleus. LSB6, the only type II PI 4-kinase 
in yeast has been shown to populate both the vacuolar and the plasma membrane. Null 
mutants of LSB6 have no detectable phenotype. In contrast, both Pik1p and Stt4p are 
essential for yeast viability. Stt4p and Pik1p create distinct PI(4)P pools that are non-
exchangeable with distinct functions (Audhya, Foti et al. 2000). The PI(4)P pools made 
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by the Pik1p at the Golgi are important in regulation of endocytosis, secretion and 
vacuolar morphology whereas the Stt4p generated PI4P pools are implicated in the 
regulation of cytoskeleton and cell wall integrity.  
The function of PI(4,5)P2 in the Golgi is less well characterized compared to its 
functions at the plasma membrane. Attempts to visualize PI(4,5)P2  at this compartment 
using fluorescence microscopy have not been successful. Evidence that suggests the 
presence of this phospholipids at the Golgi membranes came from studies conducted by 
the Shields’ labaratory (Siddhanta, Backer et al. 2000; Sweeney, Siddhanta et al. 2002). 
The localization of  PI(4,5)P2 in the Golgi complex was visualized and quantified using 
electron microscopy in cells expressing the PLCδ PH domain (Watt, Kular et al. 2002). 
PI(4,5)P2  has been shown to be important in control of ER-GC transport, in the formation 
of post-Golgi transport carriers, and in maintenance of Golgi structure. Spectrin binds to 
PI(4,5)P2 and is responsible for maintaining structural integrity of this organelle 
(Siddhanta, Radulescu et al. 2003). Dynamin-based machineries is also regulated by 
PI(4,5)P2 and is crucial for release of transport carriers from the TGN. Stimulation of 
PLD activity by PI(4,5)P2 is important for trafficking out of the Golgi through control of 
phosphatidic acid (Freyberg, Siddhanta et al. 2003).  
 
2.3.3: Golgi-localized phosphoinositide phosphatases: 
 Recruitment of distinct PI 4-kinases to Golgi complex is essential to generate 
distinct PI(4)P pools for binding of different effector proteins. The phosphoinositide 
phosphatases are equally important for maintaining the proper function of this organelle 
by terminating the PI(4)P and PI(4,5)P2 signals. However, the phosphoinositide 
phosphatases at the Golgi complex are less well characterized compared to the PI 4- 
kinases. Till date, the type II 5-phosphatase, OCRL1 (Oculocerebrorenal of Lowe) and a 
PI(4)P-phosphatase, hSAC1 (KIAA080851) were the only known phosphoinositide 
phosphatases at the Golgi complex. The function of hSAC1 and OCRL1 in Golgi 
apparatus is the main theme of this work and will be discussed in details.     
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2.3.3.1: Yeast Sac1p, the founding member of the SAC domain phosphatases 
Since its discovery as a phosphoinositide phosphatase, the cellular functions of 
Sac1p in yeasts have been studied in considerable extent in comparison to its mammalian 
counterparts. Sac1p is a type II transmembrane protein localizes to both ER and Golgi. 
The cytosolic N-terminal of  Sac1p is anchored to cellular membranes via its C-terminal  
transmembrane domains. The SAC domain is located at the N-terminal and is capable of 
dephosphorylate PI(3)P, PI(4)P and PI(3,5)P2 (Konrad, Schlecker et al. 2002). Sac1p null 
mutants accumulated eight to ten folds of PI(4)P, 1.5 folds of PI(3)P, a slightly elevated 
PI(3,5)P2 level and four folds decrease of PI(4,5)P2. Thus, Sac1p is the main 
phosphoinositide-4 phosphatase in yeasts and it plays pivotal role in controling cellular 
PI(4)P levels at the ER and Golgi (Mayinger, Bankaitis et al. 1995; Schorr, Then et al. 
2001; Tahirovic, Schorr et al. 2005).  
 
Figure 2.5:  Domain structure of yeast Sac1p 
Yeast Sac1p is a type II transmembrane PI(4)P phosphatase which contains a conserved phosphatase motif 
and two putative transmembrne domains. (Adapted from Konrad et al., 2002) 
 
Similar to mammalian Golgi, PI(4)P is also concentrated at this organelle in yeast. 
Sac1p was shown to antagonize Pik1p (homolog of mammalian PI4KIIIβ) function in the 
Golgi by terminating PI(4)P signal generated by Pik1p (Schorr, Then et al. 2001). 
Deletion of Sac1p leads to excessive anterograde transport of chitin synthases, thus 
causes specific cell wall defects. Sac1p also play pivotal role in regulating other PI(4)P 
pools made by Stt4p (the PI4KIIα homolog in mammals). This regulation is essential for 
normal endocytosis and vacuole morphology (Tahirovic, Schorr et al. 2005). In a very 
recent study, Sac1p was shown to be the main player in controling the level of PI(4)P at 
the Golgi in response to nutrients availability and cell growth condition (Faulhammer, 
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Konrad et al. 2005). During exponential cell growth, PI(4)P is needed for secretion. 
Sac1p is mainly found in the ER during active cell growth. To slow down secretion 
during starvation, Sac1p is relocated to the Golgi where it terminates PI(4)P signal at this 
organelle to slow down anterograde trafficking. In addition, the fraction of Sac1p in ER is 
required for efficient dolichol oligosaccharide biosynthesis (Faulhammer, Konrad et al. 
2005).  
 The function of Sac1p in ER was shown to be important in regulating PI(3)P and 
PI(4)P at this compartment. Retention of Sac1p in the ER stimulates ATP transport to the 
ER lumen (Konrad, Schlecker et al. 2002). Sac1p is needed in the ER to mediate ATP 
transport into this compartment for protein translocation (Mayinger, Bankaitis et al. 
1995). The function of mammalian Sac1 in ER remains unknown. 
 Sac1p is conserved from yeast to mammals. Other studies of Sac1p homologs 
have been persued in plant Arabidopsis thaliana,  Drosophila melanogaster and in higher 
eukaryotes (rat and human). The A. thaliana consists of three Sac1 genes (AtSAC1a, 
AtSAC1b and AtSAC1c) which are functional homologs of yeast Sac1p due to its ability 
to rescue cold sensitivity and inositol auxotroph in sac1-null yeast mutant (Despres, 
Bouissonnie et al. 2003). They are found to localize at ER membranes and displayed 
overlapping expression patterns. Study from Zhong et al. demonstrated that the AtSAC 
genes are essential for normal cell morphogenesis, cell wall synthesis and in salt stress 
response (Zhong, Burk et al. 2005). In contrast, Sac1p homolog in fruit fly has been 
shown to play vital role in embryonic development (Wei, Sanny et al. 2003). 
 
2.3.3.2: The mammalian SAC1 phosphatases 
The rat SAC1(rSAC1) is the first Sac1p counterpart in mammalian cells 
characterized in 2000 (Nemoto, Kearns et al. 2000). Similar to Sac1p, the rSAC1 was 
shown to exhibit phosphoinositide phosphatase activity towards 3-phosphate, 4-
phosphate and 3,5-bisphosphate. Expression of rSAC1 in ∆sac1 yeast strains 
complements a wide phenotypes associated with Sac1p insufficiency. Both Sac1p and 
rSAC1 are integral membrane lipid phosphatases at the ER and the Golgi complex 
(Nemoto, Kearns et al. 2000; Konrad, Schlecker et al. 2002). rSAC1 is ubiquitously 
expressed but highly enriched in cerebellar Purkinje cells.  
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The Homo sapiens SAC1 homolog, hSAC1 was shown to behave as the yeast 
Sac1p interms of substrate specificity and topology. Using specific antibodies against 
hSAC1, the endogenous hSAC1 was found to polulate both ER and Golgi compartments. 
Different from Sac1p, hSAC1 contains a leucine zipper motif and it  interacts with 
members of the coatomer I (COPI) (Rohde, Cheong et al. 2003). The hSAC1 gene (EST 
KIAA0851) maps to the C3CER1 segment of chromosome 3p21.3, which is found to be 
deleted commonly in SCID-derived tumors. Phosphatase inactive mutant of hSAC1 was 
found to accumulate in the Golgi and failed to bind COP1 despite of an intact putative 
COP1 interactive motif at the C-terminal. Thus, the localization of hSAC1 in both ER 
and Golgi is relied on functional phosphatase activity in addition to COP1 interaction via 
its C-terminal K(X)KXX motif (Rohde, Cheong et al. 2003). The domain structure of 
hSCA1 is shown in  Figure 2.6. 
 
Figure2.6: Domain structure of hSAC1 
hSAC1 is also a type II transmembrane protein with a large N-terminal domain containing the SAC-domain 
(aa 121-500), a putative leucine zipper (L) motif (aa 98-126), and two transmembrane domains (T) at the 
C-terminus (aa 512-543; aa 550-569). The phosphatase signature motif CX5R(T/S) (aa 389-396) is 
indicated by a black bar. (Adapted from Rohde et al., 2003)  
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hSAC2 (KIAA0966) and hSAC3 (KIAA0274) are two other SAC-domain 
containing phosphatases in human that have not been characterized in details. The 
hSAC2 functions as an inositol polyphosphate 5-phosphatase. It has a different substrate 
specificity than human and rSAC1. It can dephosphorylate PI(4,5)P2 and PI(3,4,5)P3. 
However, it prefers substrate is PI(4,5)P2 (Minagawa, Ijuin et al. 2001). The enzymatic 
activity and function of hSAC3 is currently unknown. 
 
2.3.3.3: The PI(4,5)P2 5-phosphatase OCRL1 
OCRL1 (Oculocerebrorenal of Lowe) is a phosphoinositide phosphatase that was 
found to be mutated in Lowe syndrome patients (Attree, Olivos et al. 1992). Lowe 
Syndrome is a rare X-linked disease that displayes a broad spectrum of symptoms. 
Congenital cataracts, mental retardation and Fanconi syndrome of the proximal renal 
tubules are among the hallmarks of this progressive degenerative disease. It has been 
known for almost 2 decades that pathogenesis of Lowe Syndrome is due to the deficiency 
of PI(4,5)P2 5-phosphatase activity of this Golgi localized lipid phosphatase. Kidney 
proximal tubule cells derived from Lowe patients showed accumulation of PI(4,5)P2 and 
abnormal actin cytoskeleton (Suchy and Nussbaum 2002). However, it is currently 
unknown how mutations in this lipid phosphatase can cause such tissue specific defects 
since OCRL1 is ubiquitously expressed. Interestingly, knockout mice of OCRL1 
displayed non of the described manifestations of the disease (Janne, Suchy et al. 1998). 
OCRL1 deficiency was found to be complemented in mice by Inpp5b, another inositol 
polyphosphate 5-phosphatase. 
OCRL1 has been localized predominantly to the Golgi (Olivosglander, Janne et al. 
1995; Suchy, Olivosglander et al. 1995) but a lysosomal localization has also been found 
(Zhang, Hartz et al. 1998). Very recently, this phosphatase has been shown to populate 
the endosomal membranes (Ungewickell, Ward et al. 2004; Choudhury, Diao et al. 2005). 
The C-terminal Rho-GAP domain of OCRL1 was found to bind activated GTP bound 
form of Rac small GTPase (Rho GTPase fmaily) (Faucherre, Desbois et al. 2003). It is 
believed that this interaction contribute to the steady state localization of OCRL1 at the 
TGN. However, upon stimulation of epidermal growth factor OCRL1 translocates from 
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TGN to  plasma membrane and concentrates in membrane ruffles (Faucherre, Desbois et 
al. 2003).  
 Recent studies that showed interaction of OCRL1 with clathrin and defects in 
clathrin-mediated transport between the TGN and the endosomes raised the possibility 
that trafficking between these compartments causes defects in the tissues affected with 
Lowe syndrome.  Figure 2.7 shows domain structure of OCRL1. Tissue-specific 
alternative splicing gives rise to two splice variants of OCRL1, namely OCRL1 isoform a 
and isoform b. Interestingly, the only difference between these two isoforms is the 
presence of eight amino acid insertion in the longer isoform a (Figure 2.7). Both isoforms 
are expressed in all tissues but with the shorter version being most abundant (except in 
brain). Brain tissues expressed only isoform a (the longer version of OCRL1). The 
importance of different OCRL1 splice variants is unclear at present. 
 
Figure 2.7: Domain structures of OCRL1 and Inpp5b 
Humans and mice contain two 5-phosphatases with a Rho GAP-like domain, oculocerebrorenal syndrome 
of Lowe 1 (OCRL1) and Inpp5b. OCRL1 has two splice variants, termed a and b, that contained or lack an 
eight amino acid insertion immediately adjacent to the LIDLE clathrin-binding motif. In brain, only the a 
isoform  is expressed, while b form is the major form in other tissues.(Adapted from Lowe M., 2005) 
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2.4: Aims of this work 
The scope of this work is to study the regulation of phosphoinositides (PI(4)P and 
PI(4,5)P2) at the Golgi complex by two distinct lipid phosphatases, hSAC1 and OCRL1. 
The function of PI 4-kinases in generating PI(4)P for maintenance of Golgi function and 
structural integrity is well accepted (Godi, Pertile et al. 1999; Wang, Wang et al. 2003; 
Godi, Di Campli et al. 2004). However, functional relevance of Golgi-localized PI-
phosphatases is unknown. The fact that mutations in lipid phosphatases have led to 
various malacies in humans has highlights the importance of studying compartment 
specific roles of lipid phosphatases.  
hSAC1 is the main PI(4)P-phosphatase in the ER and Golgi while OCRL1 is the main 
PI(4,5)P2 5-phosphatase at the Golgi and endosomal membranes. The interplay between 
these two phosphatases in terminating PI(4)P and PI(4,5)P2 signals at this compartment 
was investigated. 
hSAC1 is the only integral membrane lipid phosphatase found in the Golgi and 
ER. Interestingly, hSAC1 contains the putative COPI interaction motif (KXKXX) at its 
C-terminal and the active phosphatase domain has been shown to be essential for 
sufficient recruitment/interaction with COPI (Rohde, Cheong et al. 2003). Since PI(4)P is 
an anterograde trafficking signal which recruits different transport machineries at the 
TGN,  it is plausible that hSAC1 (a PI(4)P-phosphatase) is important to turn off PI(4)P 
signal for regulating Golgi function. We hypothesize a possible function of Golgi 
phosphoinositides in orchestrating functionally distinct regions/subdomains in the Golgi 
that segregates anterograde and retrograde trafficking within this organelle. 
 RNA interference (RNAi) was used to silent the expression of hSAC1 and 
OCRL1 in standard tissue culture cells. Functional analysis related to Golgi morphology, 
anterogrode trafficking from the Golgi and lipid analysis were performed in hSAC1 and 
OCRL1-depleted cells independantly. Distinct pools of Golgi phosphoinositides were 
localized, visualized and analyzed using specific antibodies and GFP-fusion proteins that 
bind PI(4)P specifically. In addition, we analyze the distribution of hSAC1 and OCRL1 
at the electron microscopy (EM) level to identify possible functional subdomains that are 
maintained by hSAC1 and OCRL1 within this organelle.  
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3 Results 
3.1: Cellular localization of hSAC1  
3.1.1: Localization of endogenous hSAC1  
 S.cerevisiae Sac1p was shown to localize to both ER and Golgi membranes 
(Whitters, Cleves et al. 1993; Foti, Audhya et al. 2001; Konrad, Schlecker et al. 2002). 
The cellular localization of rSac1 phosphatase had only been shown using indirect 
immunofluorescence against the Myc-tagged full length and the N-terminal portion of 
rSAC1 (amino acid 1-520) (Nemoto, Kearns et al. 2000). rSAC1 was found only in the 
ER. It was not clear whether hSAC1 resides only in the ER only or in both ER and Golgi 
as in yeast Sac1p. Therefore, we looked at the localization of endogenous hSAC1 using a 
specific antiserum (#69). In scanning confocal microscopy, hSAC1 was found in both ER 
and Golgi compartments as determined by colocalization with ER (Sec61α) and Golgi 
(p58) markers. The GFP-hSAC1 fusion protein is also found in both cellular 
compartments as the endogenous hSAC1 (Rohde, Cheong et al. 2003).  
 
 
Figure 3.1: Endogenous hSAC1 localized to both ER and Golgi compartments (Rohde et al., 2003). 
Hela cells were fixed with 4% formaldehyde, permeabilized using 0.4% TritonX and stained with either an 
ER marker, Sec61α or a Golgi marker, p58k. 
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3.1.2: The C-terminus of hSAC1 localizes to the ER 
Similar to yeast Sac1p, hSAC1 contains two potential transmembrane domains at 
its C-terminus (amino acid 521-543; amino acid 550-569) (Rohde, Cheong et al. 
2003)(Introduction Section 2.3.3.2). Hela cells transfected with constructs in which the 
entire N-terminal cytosolic domain of hSAC1 was deleted were found to be restricted to 
the ER (Figure 3.2). This indicates that the N-terminal portion of hSAC1 is important for 
Golgi localization of this phosphatase.  
 
 
Figure 3.2: The C-terminus of hSAC1 localized to the ER: (A) and (B): ∆NhSAC1(501-587)pEGFPC2 
and ∆NhSAC1(512-587)pEGFPC2 expressed in Hela cells. Both N-terminal mutants localized to the ER as 
shown with ER marker, Sec61β 
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3.1.3: A significant portion of hSAC1 is found at the Golgi complex 
 At steady state, hSAC1 is found in both ER and Golgi. Yeast Sac1p was shown to 
relocate to the Golgi complex during starvation to regulate secretion in response to 
growth conditions (Faulhammer et al., 2005). The shuttling mechanism is conserved from 
yeast Sac1p to hSAC1 (Blagoveschenskaya A. et al., 2006 manuscript submitted). 
However, a significant portion of hSAC1 localized to the Golgi at all times (regardless of 
growth condition). This indicates that the Golgi population of hSAC1 might have a 
constitutive function at this compartment. Furthermore, PI(4)P was reported to be 
concentrated at the Golgi complex in both yeast and mammals. Thus, it was interesting to 
investigate the function of the PI(4)P-phosphatase, hSAC1, at the Golgi in regulating 
compartment specific PI(4)P signals. 
We first looked at the Golgi distribution of endogenous hSAC1 and GFP-hSAC1 
in NIH-3T3 cells by co-localization studies with different Golgi markers (Figure 3.3). 
hSAC1 was found to be distributed throughout the cis to the trans-Golgi as shown by 
colocalization with cis, medial and trans-Golgi markers in scanning confocal microscopy 
(Figure 3.3). However, we found no complete overlap between hSAC1 and any 
individual Golgi marker. Therefore, we performed immunogold-labeling and electron 
microscopy to study the sub-Golgi distribution of hSAC1 in collaboration with Prof. 
Judith Klumperman (Utrecht, Netherlands). The GFP-hSAC1 was found to be 
concentrated at cisternal Golgi membranes in low expressing Hela cells (Figure 3.4) 
while Fapp1-PH domain (a PI(4)P-binding probe) was located at the TGN (Godi et al., 
2004). 
 
3.1.4: Detection of Golgi PI(4)P using the Fapp1-PH domain and PI(4)P antibody 
The intracellular localization of different phosphoinositide species can be studied  
using fluorescently labeled phosphoinositide binding domains (Downes, Gray et al. 2005). 
The discovery of many specific phosphoinositide binding modules had led to advances in 
visualizing phosphoinositide pools and an understanding of their spatial and temporal 
dynamics in live cells (Varnai and Balla 2006). The Fapp1-PH domain is one of the most 
studied PI-binding modules which was initially found to bind PI(4)P only (Dowler, 
Currie et al. 2000). 
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Figure 3.3: Golgi population of hSAC1 
(A): GFP-hSAC1 showed both ER and Golgi localization in NIH-3T3 cells 
(B): hSAC1 colocalized well with the trans Golgi marker, GalT-CFP, medial Golgi marker, mannosidase II 
(C) and cis Golgi marker, p24 (D). 
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Figure 3.4: Majority of hSAC1 was found at cisternal Golgi membranes while the Fapp1-PH domain 
was located at the TGN.   
Hela cells co-expressing GFP-hSAC1 and Fapp1-PH-Myc were fixed (according to Section 5.2.4.8) and 
processed for immunogold-labeling (collaboration with Klumperman’s lab). GFP-hSAC1 positive 
membranes were devoid of Fapp1-PH-Myc. Asterisk marked showed a limited co-localization of 
GFPhSAC1 and Fapp1-PH-Myc.  
 
However, recent studies by the De Matteis laboratory have shown that Fapp1-PH 
domain binds not only to PI(4)P, but also to the small GTPase Arf1 (Godi et al, 2004). 
To further confirm that the Fapp1-PH-RFP stained regions represent the PI(4)P enriched 
Golgi regions, we compared the localization of both GFP-tagged and RFP-tagged Fapp1-
PH domains with a specific PI(4)P antibody. Figure 3.5 shows that both GFP and RFP-
tagged PH-domains of Fapp1 label the same Golgi regions. However, the GFP-tagged 
probe gave a higher background of diffuse cytosolic staining. 
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Figure 3.5: Both GFP and RFP-tagged Fapp1-PH domains localized to the same Golgi regions 
The Fapp1-PH domain was fused with either GFP or RFP. Both fusion proteins localized to the perinuclear 
structures that resembled the Golgi complex where PI(4)P is highly enriched. 
 
 In addition, we found that most regions positive for Fapp1-PH staining were also 
stained by the PI(4)P antibody (Figure 3.6). However, there are non-overlapping regions 
contributed by the antibody and the Fapp1-PH domain. This suggests that there are 
additional PI(4)P pools in the Golgi that are not recognized by the Fapp1-PH domain. 
However, in both approaches to localize Golgi PI(4)P pools, we were able to confirm that 
hSAC1 is found in regions that are devoid of PI(4)P. 
 
3.1.5: hSAC1 creates low PI(4)P regions in the Golgi 
PI(4)P is the main phosphoinositide species at the Golgi complex in both yeast 
and mammals (De Matteis, Di Campli et al. 2005; Weixel, Blumental-Perry et al. 2005). 
It is well established that the Golgi associated PI 4-kinases play important roles in 
generating Golgi PI(4)P pools (Balla and Balla 2006). However, it remains largely 
unknown how the Golgi resident lipid phosphatase, hSAC1, contributes to the regulation 
of PI(4)P at the Golgi. Because PI(4)P is essential for anterograde transport carrier 
formation, we hypothesized that hSAC1 phosphatase activity may be required for 
terminating PI(4)P signals at this compartment. 
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Figure 3.6: PI(4)P staining by Fapp1-PH domain and PI(4)P antibody 
Hela cells expressing either the GFP (Top panel) or RFP-tagged Fapp1-PH domain (lower panel) were 
stained with PI(4)P antibody and viewed by scanning confocal microscopy. Both Fapp-PH domain and 
PI(4)P staining colocalized well but there were PI(4)P antibody stained regions that were not stained by the 
Fapp1-PH domain. This indicates that there are different pools of PI(4)P that are not recognized by this 
PI(4)P-binding module. 
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We therefore compared the distribution of  PI(4)P with the localization of hSAC1. To 
this end, we used a specific PI(4)P-binding probe made of the Fapp1-PH domain fused 
with RFP. hSAC1 was found enriched in Golgi regions that were not stained by the 
Fapp1-PH-RFP, usually in adjacent structures (Figure 3.7). To ensure that the Fapp1-PH-
RFP signals we observed represented PI(4)P independent of Arf1, we performed another 
co-localization study of hSAC1 and PI(4)P using a specific PI(4)P antibody (Figure 3.8). 
Both results suggested that PI(4)P and hSac1 localized to distinct regions within the 
Golgi. 
 
 
Figure 3.7: hSac1 localizes to PI(4)P-depleted Golgi regions. 
(A) NIH3T3 cells expressing FAPP1-PH-RFP (red) were stained with antibodies against hSac1 (green) 
and examined by confocal immunofluorescence microscopy. The boxed area is enlarged in the 
adjacent panel. The Scale bars represent 15µm  
(B) HeLa cells expressing FAPP1-PH-RFP (red) were stained with antibodies against hSac1 (green) and 
examined by confocal immunofluorescence microscopy. The boxed area is enlarged in the adjacent 
panel. The Scale bars represent 10µm . 
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Figure 3.8: PI(4)P and hSAC1 defined different Golgi regions 
Hela cells expressing GFP-hSAC1 were stained with a specific PI(4)P antibody. hSAC1 localizes to Golgi 
regions where PI(4)P is not present.   
 
 
 To demonstrate that the phosphatase activity of hSAC1 is reponsible for creating 
the PI(4)P-depleted regions in the Golgi, we examined the localization of a phosphatase-
dead mutant of hSAC1 (GFP-hSAC1-C/S) in relation to Fapp1-PH-RFP and PI(4)P 
antibody staining. In contrast to wild type hSAC1, the GFP-hSAC1-C/S mutant was 
found to colocalize significantly with the PI(4)P-binding probe, Fapp1-PH-RFP (Figure 
3.9A) and the PI(4)P antibody (Figure 3.9B). This result supports the idea that the 
phosphatase activity of hSAC1 is important for maintaining low PI(4)P Golgi regions. 
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Figure 3.9: PI(4)P-phosphatase activity of hSAC1 is responsible for generating PI4P-depleted regions 
in the Golgi. 
(A) Hela cells expressing both GFP-hSAC1-C/S and Fapp1-PH-RFP were fixed with 4% formaldehyde and 
examined under scanning confocal microscopy. 
(B) PI(4)P antibody staining was performed in Hela cells expressing GFP-hSAC1-C/S after fixation with 
2% formaldehyde and permeabilized with 10µg/ml digitonin in 100mM glycine PBS. In both attempts, 
GFP-hSAC1-C/S was found to localize to high PI(4)P regions  
 
3.1.6: Immunogold labeling and electron microscopy studies of Golgi subdomains 
populated by PI(4)P and hSAC1 
 The striking staining pattern of hSAC1 adjacent to the Fapp1-PH-RFP stained 
structures suggests that the Golgi complex may be organized into functional regions that 
are defined by the amount of PI(4)P. PI(4)P was shown to be concentrated at the TGN by 
a detailed analysis of intra-Golgi distribution of the Fapp1-PH domain using immunogold 
EM analysis (Godi et al., 2004). To answer the question of whether hSAC1 creates low 
PI(4)P regions within the same Golgi cisternae, we anaylzed the distribution of Fapp1-PH 
domain and hSAC1 in Hela cells by immunogold-EM (in collaboration with Judith 
Klumperman’s lab). 
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In low expressing Hela cells, there were limited positive cisternae where both 
hSAC1 and Fapp1-PH were present (Figure 3.10). However, hSAC1 and Fapp1-PH 
domains were found in the same Golgi membranes when  both fusion proteins were 
expressed at high levels (Figure 3.11). Interestingly, high level expression of Fapp1-PH 
domain caused membrane cluster formation that contained low amounts of hSAC1 
(Figure 3.12). However, high expression of hSAC1 also induced membrane networks that 
were distinct from Fapp1-PH-induced membranes (Figure 3.12). 
 These data clearly show that hSAC1 is largerly present at Golgi regions different 
from where Fapp1-PH-RFP is concentrated. The opposing gradient of PI(4)P (highly 
enriched at TGN) and the PI(4)P-phosphatase hSAC1 (enriched in cisternal membranes) 
in the Golgi indicates that hSAC1 is needed at this compartment to maintain PI(4)P-
depleted Golgi regions. hSAC1 enrichment at Golgi cisternal membranes might 
contribute to functional organization of this organelle. 
 
Figure 3.10: hSAC1 and Fapp1-PH domain showed limited colocalization in low expression Hela cells 
Hela cells transfected with GFP-hSAC1 and Myc-Fapp1-PH-RFP were fixed according to the EM fixation 
protocol described in section 5.2.4.8. GFP-hSAC1 is marked by the presence of 15nm-gold particle while 
the 10nm-gold particles represent Fapp1-PH domain. The asterisk marks a subdomain of Golgi membranes 
where both hSAC1 and Fapp1-PH domain are present.  
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Figure 3.11: Fapp1-PH-Myc and GFP-hSAC1 were located at different Golgi regions except when 
Fapp1-PH-Myc was expressed in high level. 
G: Golgi; Fapp1 positive regions that were devoid of hSAC1(left); a cluster of hSAC1 and Fapp1 positive 
membranes (right) 
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Figure 3.12: High expression of Fapp1-PH-Myc induced membrane networks that contained hSAC1 
(A) High level expression of Fapp1-PH-Myc and GFP-hSAC1 induced formation of distinct  membrane 
networks. Fapp1-PH-Myc induced membrane networks contained low amount of hSAC1(B) Fapp1-PH-
Myc and GFP-hSAC1 localized to the same membrane. 
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3.2: Depletion of hSAC1 using vector-based RNAi and synthetic siRNAs 
 
 RNAi (RNA interference) is a conserved cellular defense mechanism that is used 
by multicellular organisms against viral invasion, transposon expansion and post-
transcriptional regulation (Tuschl, Zamore et al. 1999; Zamore 2002). It has been widely 
used for functional gene studies in plants, C.elegans and D.melagogaster but its 
applications in mammalian cell lines have only become successful with the discovery of 
sequence-specific inhibition of target mRNA by using short, synthetic RNA duplexes of 
19-25bp (Elbashir, Harborth et al. 2001; Elbashir, Lendeckel et al. 2001; Elbashir, 
Harborth et al. 2002). However, this potent gene suppression technique using synthetic 
RNA is transient. To circumvent this problem, Brummelkamp et al. developed a vector-
based siRNA expression system which allowes stable expression of siRNA in 
mammalian cells over long periods of time (Brummelkamp, Bernards et al. 2002). 
Expression of short hairpin RNA (shRNA) via plasmid utilizes RNA polymerase III-
based promoters. shRNAs are then processed into siRNAs by Dicer to induce gene 
silencing via the RNAi pathway (Wu, Wu et al. 2005). 
 
 To silence the expression of hSAC1, five different RNAi constructs were 
generated using the IMGENEX pSuppressor system as described in section 5.2.1.6 . The 
potency of knocking down endogenous hSAC1 was tested by Western blotting using a 
specific antiserum against hSAC1 (#69). In addition, expression of GFP-hSAC1 was 
compared under both control and hSAC1 knock down conditions. The control RNAi 
construct was made by creating 5 point mutations to the original sequence of construct I, 
which showed the highest potency in silencing hSAC1 expression.  
 
As shown in Figure 3.13, contruct I and II show the best suppression of GFP-
hSAC1 and endogenous hSAC1. Construct I was used in subsequent experiments. 
Synthetic siRNA of the same sequence as construct I was used in parallel to the vector-
based RNAi.   
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Figure 3.13: Silencing of GFP-hSAC1 expression using vector-based RNAi 
Construct I-V were generated by cloning of oligonucleotides corresponding to hSAC1 siRNA sequences 
identified by using guide lines listed in (Harborth, 2003 ; 
http://www.rockefeller.edu/labheads/tuschl/sirna.html) . Hela cells were transfected with RNAi constructs 
together with a plasmid encoding GFP-hSAC1. Depletion of GFP-hSAC1 was determined using Western 
blot and antibodies against GFP and a loading control L23 protein. Beta-gal assay was used to measure 
transfection efficiency. 
 
Interestingly, endogenous hSAC1 appeared to be more stable than the ectopically 
expressed GFP- hSAC1 as shown in Figure 3.14 (and data not shown). The silencing 
effect could be detected 48hrs post-transfection for the GFP-hSAC1 but the endogenous 
hSAC1 depletion was observed only at 72hrs post-transfection and persisted till 120 hrs 
post-transfection. All the assays for studying the function of hSAC1 in Hela cells 
depleted of hSAC1 were performed between 72hrs to 96 hrs post-transfection.  
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Figure 3.14: Knock down of GFP-hSAC1 and endogenous hSAC1 using Vector-based RNAi . 
Construct (I) and (II) were used to deplete hSAC1. Hela cells were transfected with both RNAi plasmids 
and hSAC1-GFP. Transfection efficiency was assayed using beta-gal assay.  
 
 In addition, efficiency of GFP-hSAC1 depletion was determined by examining 
the fluorescent GFP signals in Hela cells co-transfected with GFP-hSAC1 as shown in 
Figure 3.15. Both results from Western blot (WB) and immunofluorescence (IF) showed 
that construct I was more potent than construct II in depleting hSAC1 levels. The RNAi 
silencing of hSAC1 using this vector-based method is specific because there was no 
reduction of hSAC1 in a control construct which contained 5 point mutations in the 
siRNA sequence of construct I. 
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Figure 3.15: Fluorescence micrographs showing depletion of GFP-hSAC1 using plasmids that 
expressed siRNAs against hSAC1. Hela cells transfected with different hSAC1 RNAi or control plasmids 
plus GFP-hSAC1 were fixed with 4% formaldehyde 72hrs post-transfections and viewed under the 
fluorescence microscope. 
 
 Hela cells were used in all hSAC1 knock-down experiments because it is a well 
transfected standard tissue culture cell line and with defined intracellular structures that 
can be viewed after immunostaining under standard fluorescence microscope or laser 
scanning confocal microscope. 
 
3.2.1: HPLC analysis of Hela cells depleted of hSAC1 
 PI(4)P is the major lipid substrate of the hSac1 phosphatase. To analyze the total 
cellular phosphoinositide levels in particularly PI(4)P levels that are regulated by hSAC1, 
we knocked down hSac1 expression and did HPLC analysis. Depletion of hSac1 in HeLa 
cells led to a moderate increase in total cellular PI(4)P levels but had no significant effect 
in PI(4,5)P2 level (Figure 3.16). 
   
  3 Results 
51 
 
 
 
 
 
 
Figure 3.16: HPLC analysis of Hela cells expressing hSAC1 RNAi and Control plasmids. 
(A) Hela cells depleted of hSAC1 were labeled with 10µCi/ml of  [3H]-myo-inositol to steady state for 12 
hours. Lipids were extracted, deacylated and anaylzed using HPLC. 
(B) HPLC analysis of phosphoinositides in Hela cells treated with hSAC1 siRNA. 
 
This analysis showed that hSAC1 is a PI(4)P-phosphatase. Although changes in 
total PI(4)P levels is not as drastic as in the yeast Sac1p null mutants, local changes of 
PI(4)P pools in hSAC1 knock down cells might be sufficient in affecting compartment 
specific function. Therefore, we examined local changes of PI(4)P in hSAC1 depleted 
cells by PI(4)P antibody staining. 
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3.2.2: Elevated levels of PI(4)P in hSAC1-depleted cells are found at the plasma 
membrane and vesicular like structures 
 
 The increased levels of PI(4)P detected by HPLC were also supported by 
immunofluorescence studies of PI(4)P staining using a specific antibody in hSAC1 knock 
down cells. Under control conditions, PI(4)P was confined to the Golgi. In contrast, 
hSAC1-depleted cells showed a highly increased signal of PI(4)P and additional PI(4)P 
staining of other cellular compartments besides the Golgi. The plasma membrane and 
cytosolic vesicular structures were stained positive with PI(4)P antibody (Figure 3.17). 
This is in line with a recent report which shows that Sac1p null mutants have 
accumulation of PI(4)P in the endosomal compartment,  ER and the plasma membrane 
(Tahirovic et al., 2005). These findings strongly support the idea that hSAC1 is a spatial 
regulator for restricting PI(4)P to specific Golgi regions. 
 
 In addition to accumulation of PI(4)P at Golgi membranes and other cellular 
compartments, N-acetylglucosaminyltransferase I (NacT1) was found to mislocalize in 
hSAC1-depleted cells (Figure 3.17). NacT1GFP was found to localize to the cell 
periphery in addition to diffuse, punctate vesicule-like structures. In control cells, 
NacT1GFP was only found at the Golgi compartment. 
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Figure 3.17: Depletion of hSAC1 abolished the spatially restricted distribution of PI(4)P at Golgi 
membranes. 
Hela cells treated with control or hSAC1 siRNAs were co-transfected with NacT1GFP as transfection 
marker. Cells were fixed with 2% formaldehyde 72hrs post-transfection and permeabilized using digitonin 
as described in section 5.2.4.3. PI(4)P staining was restricted at Golgi membranes in control cells while 
hSAC1-depleted cells showed extensive PI(4)P staining at Golgi, plasma membrane and vesicule-like 
structures. 
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3.2.3: Golgi resident enzymes are preferentially located at low PI(4)P Golgi regions 
 
The observation that PI(4)P staining did not colocalize with NacT1GFP suggests 
that NacT1GFP or other Golgi resident enzymes might be preferentially located at low 
PI(4)P Golgi regions. To test this hypothesis, we examined the localization of Golgi 
resident enzymes in relation to PI(4)P.We further examined the localization of two Golgi 
resident enzymes, mannosidase II (ManII) and NacT1 with PI(4)P in Hela cells. Cells 
were fixed with 2% formaldehyde, stained with a PI(4)P antibody and examined under 
the scanning confocal microscope. We found that both enzymes localized to Golgi 
regions that were devoid of PI(4)P (Figure 3.18). This staining pattern is reminiscent of 
that of our hSAC1 and PI(4)P co-localization studies.  
 
 
 
Figure 3.18: Golgi resident enzymes NacT1GFP and Man II are found in PI(4)P depleted Golgi 
regions 
Hela cells transfected with NacT1GFP or non-transfect cells were fixed with 2% formaldehyde, 
permeabilized with digitonin and stained with PI(4)P antibody. Cells were examined under a scanning 
confocal microscope. 
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3.2.4: Depletion of hSAC1 causes mislocalization of Golgi resident enzymes and 
aberrant Golgi morphology 
 PI(4)P is important for maintaining functional and structural integrity of the Golgi 
complex. This was shown by depletion of PI 4-kinases which causes Golgi fragmentation 
and inhibition of anterograde transport (Godi et al., 2004; Wang et al., 2003). hSAC1 is 
the only known PI(4)P-phosphatase in the Golgi. The observation that ManII and NacT1 
are preferentially localized to PI(4)P-depleted Golgi regions suggests that the low PI(4)P 
Golgi regions defined by the presence of hSAC1 may be important for the recycling of 
Golgi resident enzymes, while cargo that is exported from the Golgi is concentrated at 
high PI(4)P Golgi regions. Furthermore, we had shown that hSAC1 interacts with COPI 
(Rohde et al., 2003) and this interaction is also dependent on its phosphatase activity. 
Thus, an active PI(4)P-phosphatase hSAC1 may be essential in generating low PI(4)P 
Golgi regions that are important for recycling of resident Golgi enzymes via the COPI 
vesicles.  
 Therefore, we examined Golgi morphology by immunostaining and fluorescence 
microscopy in Hela cells depleted of hSAC1 using different Golgi markers (TGN46, 
ManII and NacT1GFP). Hela cells treated with either control or hSAC1 siRNAs were 
fixed and stained with specific antibody against ManII and TGN46 (Figure 3.20). For 
NacT1, we co-transfected a GFP-fusion protein of NacT1 together with hSAC1 siRNA or 
control RNAs and co-stained with ManII antibody. We found that both ManII and NacT1 
were mislocalized in hSAC1-depleted cells. Both enzymes were found at the cell 
periphery and diffuse vesicular structures instead of a normal perinuclear dense structure 
(Figure 3.19). In most cases, cells that showed cell surface localization of both enzymes 
also had remnants of Golgi-like staining. 
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 Figure 3.19: Depletion of hSAC1 causes mislocalization of Man II and NacT1. 
Hela cells transfected with control or hSAC1 siRNAs and NacT1GFP were fixed with 4% formaldehyde 
and stained with ManII antibody. ManII and NacT1GFP showed perinuclear dense structures in control 
cells but were mislocalized to the cell periphery in hSAC1 depleted cells. 
 
 
 
Figure 3.20: Depletion of hSAC1 causes mislocalization of Man II 
Hela cells transfected with control or hSAC1 siRNAs were fixed with 4% formaldehyde and stained with 
Man II  and TGN46 antibodies. ManII and TGN46 showed perinuclear dense structures in control cells but  
ManII was mislocalized to the cell periphery and vesicular, tubular-like structures in hSAC1 depleted cells. 
TGN46 staining was indistinguishable in both control and knock down cells.  
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3.2.5: Mislocalization of ManII and NacT1 in hSAC1-depleted cells could be rescued 
by ectopic expression of RNAi resistant wild type hSAC1 
To further show that the mislocalization of Man II and NacT1 is hSAC1 RNAi 
specific and dependent on the phosphatase activity of hSAC1, we generated two specific 
RNAi-resistant hSAC1 constructs by introducing silent mutations in the nucleotide 
sequence targeted by the RNAi construct. Figure 3.21 and Figure 3.22 show 
immunofluorescence in Hela cells expressing either the RNAi resistant wild type hSAC1 
(GFP-hSAC1*) or the RNAi resistant phosphatase dead mutant (GFP-hSAC1-C/S*). 
Expression of the GFP-hSAC1* rescue plasmid in siRNA treated Hela cells could rescue 
the mislocalization phenotype while the mutagenized phosphatase dead plasmid did not 
rescue. ManII was found localized at the Golgi in knock down cells expressing the GFP-
hSAC1* rescue plasmid. On the other hand, ManII was still mislocalized at the cell 
periphery and in punctate diffused structures in hSAC1 siRNA treated cells expressing 
the RNAi resistant phosphatase-dead mutant (GFP-hSAC1-C/S*). This further 
demonstrated that the mislocalization of resident Golgi enzymes was dependent on the 
phosphatase activity of  hSAC1.  
 
Figure 3.21: Localization of ManII in control cells transfected with either RNAi resistant plasmid 
GFP-hSAC1* or GFP-hSAC1-C/S* 
Hela cells were transfected with control siRNAs and plasmids encoding either the GFP-hSAC1* 
(mutagenized rescue plasmid) or GFP-hSAC1-C/S* (mutagenized phosphatase-dead hSAC1). Cells were 
fixed and stained with ManII 72hrs post-transfection and examined under the fluorescence microscope.  
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Figure 3.22: Mislocalization of ManII could be rescued by an ectopically expressed RNAi resistant 
wild type hSAC1 (GFP-hSAC1*) 
Hela cells were transfected with hSAC1 siRNA or control together with either GFP, GFP-hSAC1* or GFP-
hSAC1-C/S* and stained with ManII antibody. ManII was found to mislocalize to the cell periphery and 
punctate structures except in cells co-expressing GFP-hSAC1* 
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3.2.6: Cell surface biotinylation of NacT1GFP in hSAC1-depleted cells 
 Cell surface localization of NacT1 in hSAC1 RNAi cells was indepently 
confirmed by surface biotinylation and streptavidin pull-down of NacT1GFP (Figure 
3.22). Hela cells were transfected with control or hSAC1 siRNAs together with 
NacT1GFP. In addition, we were able to show that cell surface expression of  NacT1GFP 
in hSAC1-depleted cells could be abolished by ectopic expression of the RNAi resistant 
wild type hSAC1 (Figure 3.22, panel 4) but not the RNAi resistant phosphatase-dead 
mutant (GFP-hSAC1-C/S*, Figure 3.22, panel 3). The amount of detected biotinylated 
NacT1GFP was less in Hela cells co-expressing the non-rescue GFP-hSAC1-C/S* and 
hSAC1 siRNA (panel 3). This was due to reduced expression of NacT1GFP (less input 
NacT1GFP in 3, 4 compared to 1 and 2). In conclusion, the cell surface localization of 
resident Golgi enzyme, NacT1GFP was a consequence of hSAC1 depletion. 
 
Figure 3.23: Cell surface biotinylation of NacT1GFP in Hela cells depleted of  hSAC1 
1: Hela cells transfected with control siRNAs and NacT1GFP 
2: Hela cells transfected with hSAC1 siRNAs and NacT1GFP 
3: Hela cells transfected with hSAC1 siRNAs, NacT1GFP and RNAi resistant phosphatase dead mutant, 
GFP-hSAC1-C/S* plasmid 
4: Hela cells transfected with hSAC1 siRNAs, NacT1GFP and RNAi resistant wild type hSAC1, GFP-
hSac1* plasmid. 
A. Biotinylated NacT1GFP detected using an antibody against GFP after pulldown via biotin 
B. Endogenous hSAC1 depletion by RNAi while the RNAi resistant GFP-hSAC1C/S* and GFP-
Sac1* were detected using aGFP antibody. Total input of NacT1GFP (1/40 of total) detected using 
a GFP antibody. GAPDH was used as loading control. 
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3.2.7: Aberrant Golgi morphology and mislocalization of Golgi enzymes are not a 
consequence of apoptosis 
 Cell surface localization of Golgi resident enzymes, ManII and NacT1 was 
dependent on hSAC1 depletion. In addition to cell surface staining of both enzymes, the 
vesicular-diffuse staining of both enzymes in hSAC1-depleted cells resembled Golgi 
fragmentation during apoptosis. To rule out the possibility that the aberrant Golgi 
phenotype observed in hSAC1 knock down cells was a consequence of apoptosis, we 
carried out apoptosis tests in Hela cells depleted of hSAC1.  
 We first examined nucleus integrity by DAPI staining in control and hSAC1 
knock down cells. NacT1GFP was co-transfected with control or hSAC1 siRNAs as 
markers for transfected cells. In addition, we monitored the mislocalization phenotype in 
comparison with nuclear DAPI staining. We found no difference in DAPI staining for 
hSAC1-depleted cells compared to control cells. The nucleus was still intact even when 
NacT1GFP was found at the cell periphery or in vesicular structures in hSAC1 knock 
down cells (Figure 3.23). 
 In addition, we looked at an early apoptosis marker in hSAC1 siRNA treated cells. 
Poly(ADP-ribose) polymerase (PARP) is one of the first substrate cleaved by the 
caspases during onset of apoptosis (Soldani, Lazze et al. 2001; Soldani and Scovassi 
2002). PARP synthesizes ADP-ribose using NAD in response to DNA strand breaks and 
is involved in many genomic processes such as DNA base excision repair, DNA 
replication, and transcription (Schreiber, Dantzer et al. 2006). Figure 3.24 shows Western 
blot analysis of Hela cell lysates from hSAC1 siRNA or control transfected cells and 
probe with a specific antibody against PARP. Full-length PARP (116kDa) was cleaved 
into a 85kDa band and a 26kDa band (that was not detected by the monoclonal antibody) 
in Hela cells treated with an apoptosis inducer, staurosporine (a kinase inhibitor). No 
cleavage of PARP was observed in hSAC1 knock down cells or in control cells. This 
result further showed that the observed Golgi phenotype in hSAC1-depleted cells was not 
caused by apoptosis. 
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Figure 3.24: Depletion of hSAC1 causes mislocalization of NacT1GFP but does not cause apoptosis. 
Hela cells were co-transfected with hSAC1 siRNA/control RNAs together with NacT1GFP, and stained 
with DAPI to monitor nuclear integrity. Only staurosporine treated mock transfected cells showed nuclear 
disintegration. 
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Figure 3.25: Analyzing PARP cleavage in Hela cells treated with hSAC1 siRNA  
1: Hela cells treated with hSAC1 siRNA 
2: Hela cells treated with control siRNA 
3: Hela cells treated with control siRNA and staurosporine 
4: Hela cells treated with staurosporine 
PARP cleavage was observed only in Hela cells treated with apoptosis inducer, staurosporine. 
Depletion of hSAC1 does not cause apoptosis. 
 
 
3.2.8: Measuring bulk secretion and MHC-I trafficking in hSAC1-depleted Hela 
cells  
 To study the consequences of hSAC1 depletion in secretion, a bulk secretion 
assay which measured the whole secretory cargo traverse through the secretory pathway 
was employed. To determine trafficking of proteins out of  the TGN, Hela cells depleted 
with hSAC1 were pulse-labeled with [35S]-Methionine/Cystein and post-Golgi trafficking 
was blocked by imposing a reversible low temperature (18˚C) block on Golgi trafficking. 
Appearance of [35S]-labeled proteins in the culture medium was monitored after shifting 
the temperature back to 37˚C. However, knock down of hSAC1 did not change bulk 
Golgi secretion (Figure 3.26)  
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Figure 3.26: Depletion of hSAC1 did not affect anterograde bulk secretion 
Hela cells transfected with either hSAC1 siRNA or control RNA were pulsed labeled with [35S]-
Methionine/Cystein and incubated at 18˚C for 3 hrs. The [35S]-labeled proteins in the culture medium was 
monitored after shifting the temperature back to 37˚C. 
 
 The bulk secretion result in hSAC1 siRNA treated cells was somewhat surprising. 
We anticipated that anterograde trafficking might be affected since PI(4)P was shown to 
be important for forward trafficking from the TGN to the plasma membrane (Godi, Di 
Campli et al. 2004; De Matteis, Di Campli et al. 2005). Thus, we further investigated 
anterograde transport from TGN to plasma membrane by monitoring a specific cargo, the 
Major Histocompatibility Complex Class I molecules (MHC-I). Anterograde transport of 
MHC-I was determined by cell surface biotinylated MHC-I normalized to the total 
cellular  MHC-I. To this end, Hela cells treated with either control or hSAC1 siRNA 
were pulse-labeled with 35S-Methionine/Cystein for 15 min at 37˚C and incubated at 
18˚C for 3 hours (temperature block to accumulate labeled MHC-I at the TGN). Cells 
were chased at 37˚C at various time points, cell surface MHC-I was biotinylated and total 
MHC-I was immunoprecipitated using a specific MHC-I antibody. The biotinylated 
MHC-I was then precipitated using streptavidin-agarose beads. We found that MHC-I 
trafficking was slightly affected in hSAC1-depleted cells (Figure 3.27). We reasoned that 
depletion of hSAC1 only affected MHC-I trafficking but not bulk secretion. Perhaps 
hSAC1 phosphatase activity was only important for trafficking of specific cargo proteins, 
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such as the highly glycosylated protein MHC-I. Whether there are glycosylation defects 
in hSAC1 knock down cells is currently under investigation. 
 
Figure 3.27: MHC-I surface biotinylation in Hela cells treated with hSAC1 siRNAs 
Control or hSAC1 siRNA treated cells were pulse-labeled for 15 min at 37˚C followed by a reversible low 
temperature block of Golgi trafficking at 18˚C. Cells were then shifted back to 37˚C and cell surface 
biotinylation of MHC-I was carried out at different time points after temperature block release (0, 10 and 
30 min). Biotinylated MHC-I and total MHC-I were quantified and expressed as biotinylated MHC-I over 
total MHC-I.  
 
3.3: Splice variants of OCRL1 
OCRL1 has two splice variants: isoform a (OCRL1-a) and isoform b (OCRL1-b). 
OCRL1-a contains an additional 8 amino acids. This stretch is adjacent to the clathrin 
binding motif that is present in both isoforms (Lowe 2005)(Introduction Figure 2.7). The 
functional relevance of OCRL1 splice variants is unknown. To study the cellular 
localization and function of OCRL1 splice variants, we generated antiserum that 
recognized both isoforms and one that was immunoreactive to OCRL1-a only. Figure 
3.28 shows localization of GFP-OCRL1-b and OCRL1-a using the isoform specific 
antibody in COS7 cells. Interestingly, both isoforms showed distinct localization. The 
short version OCRL1-b localized to the Golgi (in particularly TGN,(Choudhury, Diao et 
al. 2005) and some punctate staining while OCRL1-a showed punctate staining that was 
reminiscent of endosomal/lysosomal compartments.  
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To characterize these punctate structures, we used different endosomal markers 
and performed immunofluorescence studies. OCRL1-b has been shown to localize to the 
early endosomes in addition to the TGN localization (Ungewickell, Ward et al. 2004; 
Choudhury, Diao et al. 2005). We could confirm that OCRL1-b populates the early 
endosomal membranes besides TGN (Figure 3.29). The punctate structures in GFP-
OCRL1-b  showed clear colocalization with EEA1(Figure 3.29) but not with the 
late/lysosomal marker, lamp2 (Figure 3.30). Conversely, OCRL1-a was found only at the 
late endosomal/lysosomal compartment as determined by colocalization study using 
lamp2 (Figure 3.31). However, the punctate structures stained by the OCRL1-a specific 
antibody did not overlap completely with lamp2 (Figure 3.31). This indicates that 
OCRL1-a might be present on other sub-endosomal/lysosomal compartments that were 
not stained by Lamp2. We attribute this differential localization of OCRL1-a and 
OCRL1-b to the 8 amino acid acidic cluster that is present in OCRL1-a. Our results 
suggest that there are distinct endosomal pools of OCRL1 that might play an important 
role in regulating phosphoinositide levels at these compartments. Even though the 
preferred substrate of OCRL1 is PI(4,5)P2 , OCRL1 also exhibits activity towards 
PI(3,4,5)P3 and PI(3,5)P2 (Zhang, Jefferson et al. 1995; Schmid, Wise et al. 2004) which 
are the main phosphoinositides at the endosomal membranes. However, more 
experiments will be needed to characterize the function of the OCRL1 isoforms at their 
distinct endosomal compartments. 
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Figure 3.28: Colocalization study of OCRL1 isoform b and OCRL1 isoform a. 
Cos7 cells transfected with GFP-tagged OCRL isoform b were stained with isoform a specific antibody. 
Isoform b is mainly localized to the Golgi (and some punctate structures) while isoform a is found at 
punctate like structures reminiscent of endosomal/lysosomal compartments 
 
 
 
 
Figure 3.29: GFP-OCRL1-b is found at early endosomes in addition to the TGN 
Cos7 cells expressing GFP-OCRL1-b were fixed with 4% formaldehyde and stained with an early 
endosomal marker, EEA1. The OCRL1 isoform b was found predominantly at the TGN with punctate 
structures that were stained positive for EEA1. 
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Figure 3.30: OCRL1 isoform b is not present at the late endosomal/lysosomal compartment 
Cos7 cells expressing GFP-OCRL1-b were stained with Lamp2 antibody and view under laser scanning 
confocal microscope. The punctate structures of GFP-OCRL1-b do not stained positive with Lamp2. 
 
 
 
Figure 3.31:OCRL1 Isoform a is found in subpopulation of late endosomal/lysosomal membranes 
that are stained positive with Lamp2 
Cos7 cells were fixed with 4% formaldehyde and stained with antibodies against OCRL1 isoform a and a 
late endosomal/lysosomal marker, lamp2. The punctate structures stained by the isoform a specific 
antibody showed partial colocalization with lamp2.  
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In addition, we also compared the localization of GFP-OCRL1-b expressed in 
COS7 cells with an antibody that recognized both isoforms of OCRL1 (Figure 3.32). As 
predicted, both GFP-OCRL1-b and the antibody staining colocalized very well at the 
TGN but showed no colocalization between the isoform specific endosomal population of  
OCRL1.  
 
 
 
 
 
Figure 3.32:Antibody staining using antiserum that recognized both isoforms of OCRL1 showed 
colocalization at the Golgi-like structure but not the punctate endosomal like structures. 
Cos7 cells transfected with GFP-OCRL1-b were stained with a specific antibody that recognized both 
isoforms of OCRL1. The antibody staining colocalized well with the Golgi population of GFP-OCRL1-b 
but there were punctate like structures of isoform a (red) that were not present in isoform-b.  
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3.3.1: Investigation of the cellular function of Golgi localized OCRL1-b  
 How PI(4,5)P2 at the Golgi complex is regulated by lipid phosphatases is unclear. 
The fact that the steady state level of Golgi PI(4,5)P2 is 9 folds lower than that of the 
plasma membrane PI(4,5)P2 (Watt, Kular et al. 2002) suggests that PI(4,5)P2 at this 
compartment is highly dynamic. OCRL1-b is the only Golgi-localized PI(4,5)P2 5-
phosphatase known so far. Thus, it is a prime candidate for studying the dynamics of 
PI(4,5)P2 regulation at the Golgi. We started our studies by investigating the cellular 
localization of OCRL1 in relation to hSAC1. The aim was to examine whether OCRL1 
generated PI(4)P pools from PI(4,5)P2 that are further metabolized by hSAC1 or whether 
these two phosphatases were in distinct subdomains in the Golgi with different functions. 
Consistent with previous studies (Dressman, Olivos-Glander et al. 2000; 
Choudhury, Diao et al. 2005), we found that GFP-OCRL1-b localized to the TGN as 
shown in Figure 3.33.   
 
 
 
 
Figure 3.33: GFP-OCRL1-b is localized to the TGN 
Cos7 cells expressing isoform b of GFP-tagged OCRL were immunostained with a TGN marker, TGN46. 
 
When we examined OCRL1-b and hSAC1 distribution in the Golgi, we found no 
or very little overlap between the two phosphatases. OCRL1-b was found to populate 
regions in the Golgi that were distinct from where hSAC1 resided (Figure 3.34).  
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Figure 3.34: OCRL1 and hSAC1 populate distinct Golgi regions 
Confocal immunofluorescence of hSAC1(red) and OCRL1(green) in Hela cells. Both phosphatases did not 
colocalize.  
 
Furthermore, when we examined PI(4)P staining using Fapp1-PH-RFP and PI(4)P 
antibody in Hela cells expressing GFP-OCRL1-b, this PI(4,5)P2 5-phosphatase co-
localized almost completely with FAPP1-PH-RFP and PI(4)P antibody staining (Figure 
3.35), indicating that the localization of hSAC1 and OCRL1 to distinct Golgi regions was 
mutually exclusive and thus suggesting that formation of PI(4)P and of PI(4,5)P2-
depleted regions occurred at distinct sites.  
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Figure 3.35: OCRL1 is found in PI(4)P positive Golgi regions 
(A) OCRL1 was found in high PI(4)P Golgi regions. Different from hSAC1, OCRL1 co-localized almost 
completely with PI(4)P-binding domain, Fapp1-PH-RFP. This finding suggests that both phosphatases are 
located at different Golgi subcompartments.  
(B) PI(4)P-specific antibody was used to detect  PI(4)P in Hela cells expressing GFP-OCRL1-b. GFP-
OCRL1-b colocalized well with PI(4)P.  
 
Figure 3.36: Electron micrograph showing GFP-OCRL1-b and Fapp1-PH-Myc labeled by 
immunogold. 
Hela cells co-expressing GFP-OCRL1-b and Fapp1-PH-Myc were fixed according to Section 5.2.4.8.Cells 
were processed for immunogold labeling and electron microscopy (collaboration with Klumperman’s lab)   
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3.3.2: Depletion of OCRL1 using vector-based RNAi  
 
 To study the function of Golgi localized PI(4,5)P2 5-phosphatase OCRL1, three 
different RNAi constructs and a control plasmid containing four point mutations were 
generated. All three constructs were tested and showed successful knock down of 
OCRL1 in HEK293 cells, which have a high level of expression of this phosphatase. 
Construct OCRL1-A and OCRL1-C show equal potency in depleting OCRL1 (Figure 
3.36). All subsequent experiments were performed using construct A. In general, 
depletion of OCRL1 can be observed between 48 hrs-72 hrs post-transfections. All 
experiments were carried out between 60 hrs to 72 hrs post-transfections.   
 
 
 
Figure 3.37: Depletion of OCRL1 by Vector-based RNAi 
HEK293 cells were transfected with plasmids encoding siRNAs targeted to OCRL1 and a control plasmid 
that expressed siRNAs which contained 4 point mutations. Lane 1 & 2: RNAi construct A; lane 3 & 4: 
RNAi construct B and lane 5&6: RNAi construct C. GAPDH was used as a loading control. 
 
 We also monitored the extend of OCRL1 depletion by examining the GFP signal 
in HEK293 cells co-transfected with GFP-OCRL1 and either control or RNAi plasmids. 
In control plasmid transfected cells, the GFP signal was observed but not in OCRL1 
RNAi plasmid A and B transfected cells (Figure 3.37). 
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Figure 3.38: Depletion of OCRL1-GFP in HEK293 cells  
HEK293 cells transefected with OCRL1-GFP and  plasmids expressing either the control or siRNAs 
directed to OCRL1. Cells were fixed in 4% formaldehyde and viewed under fluorescence microscope.  
 
3.3.3: HPLC analysis of HEK293 cells-depleted of OCRL1 
 
 
Figure 3.39: Depletion of OCRL1 causes accumulation of PI(4,5)P2  
(A) Depletion of OCRL1 using RNAi in HEK293 cells. Cells were labeled with 10µCi/ml of  [3H]-myo-
inositol to steady state for 12 hours. Lipids were extracted, deacylated and anaylzed using HPLC.  
(B) HPLC analysis of phosphoinositides in HEK293 cells treated with OCRL1 siRNA. OCRL1-depleted 
cells showed accumulation of PI(4,5)P2 but no significant effect on PI(4)P level. 
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 The main substrate of OCRL1 is PI(4,5)P2 (Zhang, Jefferson et al. 1995). Cell 
lines from Lowe syndrome patients exhibited accumulation of PI(4,5)P2(Zhang, Hartz et 
al. 1998). To examine the cellular levels of PI(4,5)P2 in OCRL1-depleted cells, we 
performed HPLC analysis in HEK293 cells depleted of OCRL1 (Figure 3.38). OCRL1 
knock-down lead to elevated cellular PtdIns(4,5)P2, similar to the levels determined in 
cells from a Lowe syndrome patient. Thus, depletion of OCRL1 in tissue culture cells 
using RNAi could phenocopy the absence/dysfunction of OCRL1 . 
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3.3.4: Depletion of OCRL1 does not cause alterations in Golgi morphology 
 To address the question whether depletion of  the Golgi localized PI(4,5)P2 5-
phosphatase causes abberant Golgi morphology and mislocalization of Golgi enzymes, 
we looked at the localization of NacT1 and ManII in Hela cells depleted of OCRL1 
(Figure 3.39). NacT1 and ManII in OCRL1 siRNA treated cells showed similar 
perinuclear localization as in control cells. Thus, knock down of OCRL1 does not affect 
Golgi morphology.  
 
 
 
Figure 3.39: Depletion of OCRL1 does not cause abberant Golgi morphology 
Hela cells transfected with NacT1GFP and OCRL1 siRNA or control RNA were fixed with 4% 
formaldehyde and stained with ManII antibody. Both OCRL1 siRNA and control cells show similar 
staining of both Golgi resident enzymes. 
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3.3.5: Depletion of OCRL1 causes defect in bulk secretion 
 The striking overlap between cellular OCRL1 and PI(4)P distribution suggests 
that OCRL1 may play a role in maintaining high PI(4)P Golgi regions by metabolizing 
PI(4,5)P2 to PI(4)P. PI(4)P is an anterograde trafficking signpost at the Golgi, thus it was 
interesting to examine whether bulk anterograde trafficking was affected by depletion of 
OCRL1. Bulk antergograde trafficking was carried out in OCRL1-depleted HEK293 cells 
as described in Section 3.2.9 and Section 5.2.4.7.1. 
 
 
 
Figure 3.40: Bulk secretion was inhibited in HEK293 cells-depleted of OCRL1 
HEK293cells were transfected with plasmids for expressing siRNAs directed against Ocrl1 or control 
RNAs . Three days after transfection cells were pulse labeled with [35S]Met/Cys, incubated at 18˚C for 3h 
and then shifted to 37˚C. At the indicated times, radio-labeled proteins in the culture supernatants and 
inside the cells were precipitated, collected on filters and quantified by scintillation counting. As an 
additional control, the secretion assay was performed 4˚C. The depicted data are means +/- SD from 
triplicates derived in three independent sets of experiments. 
 
 We found that knock down of OCRL1 caused defect in bulk anterograde 
trafficking. This indicates that the PI(4,5)P2 5-phosphatase activity of OCRL1 is 
important for maintaining constitutive secretion from TGN to the plasma membrane.  
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4 Discussion 
 In this study, I investigated the functions of two lipid phosphatases, hSAC1 and 
OCRL1 at the Golgi complex. hSAC1 is a PI(4)P-phosphatase localized to both the ER 
and Golgi (Rohde et al., 2003), while OCRL1 is a PI(4,5)P2 5-phosphatase found at the 
TGN and endosomes (Ungewickell, Ward et al. 2004; Choudhury, Diao et al. 2005). My 
work was focused on the functions of both phosphatases at the Golgi complex and how 
compartment-specific pools of PI(4)P and PI(4,5)P2 at this organelle are regulated.  
Recent work by different laboratories has established that PI(4)P is the main 
phosphoinositide species at the Golgi (De Matteis and Godi 2004; De Matteis, Di Campli 
et al. 2005) where it contributes to the maintenance of structural and functional integrity 
of this organelle (Godi, Pertile et al. 1999; Wang, Wang et al. 2003; Godi, Di Campli et 
al. 2004). In addition, PI(4)P at the Golgi complex serves as an organelle specific signal 
for recruitment of cellular machineries such as the adaptor proteins involved in 
membrane trafficking. The functions of PI 4-kinases in generating these PI(4)P pools 
have been studied in considerable detail (Balla 1998; Balla and Balla 2006). These PI 4-
kinases are either tightly associated with the Golgi membranes (PI4KIIα) or recruited to 
the Golgi by activation of the small GTPase, Arf1(PI4KIIIβ). In contrast, the function of 
lipid phosphatases at this compartment has remained unclear. The fact that many human 
diseases are linked to mutations in phosphatases highlights the importance of 
phosphatases in antagonizing or terminating signals at the proper space and time. 
Mutations in OCRL1 cause a severe X-linked disease, Lowe syndrome. The tissue 
specific manifestations of Lowe syndrome (congenital cataracts, Fanconi syndrome and 
mental retardation) suggest that tight regulation of PI(4,5)P2 by this 5-phosphatase is 
critical for the proper function of specific tissues. To elucidate the etiology of Lowe 
syndrome, it is necessary to study the compartment-specific functions of OCRL1 and to 
understand how dysfunction of this phosphatase affects PI(4,5)P2-regulated cellular 
events such as membrane trafficking. Although hSAC1 has not been linked to any known 
human diseases, this phosphatase is mapped to the C3CER1-segment on chromosome 3 
(3p21.3) that is commonly eliminated in SCID-derived tumors (Rohde et al., 2003). This 
1.4Mb chromosome segment that contains 19 active genes with possible tumor- 
suppressing properties (Kiss, Yang et al. 2002). The very recent finding that SAC1 
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shuttles between ER and Golgi in response to growth conditions (Faulhammer F. et al., 
2005, Blagoveschenskaya A. et al., 2006 manuscript submitted) indicates that SAC1 
phosphatase might be essential for regulating cell growth. To further characterize lipid 
signaling at the Golgi, it was important to study the function of hSAC1 and OCRL1, in 
particular their compartment specific roles. 
RNA interference (RNAi) was employed to silence the expression of  hSAC1 and 
OCRL1 in tissue culture cells followed by different functional assays to address 
compartment-specific roles of both phosphatases. We started our studies by generating 
different plasmid DNA constructs that express small interfering RNAs (siRNAs). 
Although selection of different siRNA sequences was done according to stringent 
guidelines (Harworth et al., 2003), the potency of gene suppression varied to great extent. 
However, in both attempts to deplete hSAC1 and OCRL1 using RNAi, I successfully 
generated two or more effective silencing constructs for each phosphatase.  
 
4.1: hSAC1 is a PI(4)P-phosphatase found in both ER and Golgi 
The ER localization of SAC1 phosphatase has been established in both yeast and 
mammals. However, the extent of Golgi localization of SAC1 phosphatase was not clear. 
In rats, SAC1 was found at ER membranes only by indirect immunofluorescence studies 
(Nemoto et al., 2000). However, our data clearly shows that the endogenous hSAC1 is 
found in both ER and Golgi membranes (Rohde et al., 2003). This is also supported by 
recent publications that yeast Sac1p is present at the Golgi in addition to the ER (Schorr  
et al, 2001; Faulhammer et al., 2005). Interestingly, expression of N-terminal truncated 
version of hSAC1 showed restricted ER localization. Thus, the N-terminal cytosolic 
domain of hSAC1 (which contains the SAC-phosphatase domain and the leucine zipper 
motif) is essential for Golgi targeting. The mechanism of how cellular distribution of 
hSAC1 is regulated remains unclear. In yeast, the interaction between Sac1p and Dpm1p 
(an ER-specific enzyme, dolicholphosphatemannose synthase) is essential for ER 
localization of Sac1p and efficient oligosaccharide biosynthesis during exponential 
growth conditions (Faulhammer et al. 2005). In contrast to yeast Sac1p, the ER 
localization of mammalian Sac1 is mediated by a canonical coatomer complex I (COPI)-
binding motif missing in the S.cerevisiae Sac1p (Rohde et al., 2003). Furthermore, the 
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dynamics of ER and Golgi localization of hSAC1 was shown to be dependent on its 
phosphatase activity and its efficiency in COPI binding (Rohde et al., 2003). Mutating the 
dilysine motif at the C-terminal KEKID COPI-binding site of hSAC1 (hSAC1-K2A 
mutant) led to Golgi accumulation of hSAC1. When we compared the Golgi localization 
of the hSAC1-K2A mutant with wild type hSAC1, both wild type and hSAC1-K2A 
mutant localized to different Golgi regions (data not shown). This finding supports the 
idea that active retrieval of hSAC1 is important for steady state ER and Golgi distribution 
of this lipid phosphatase.  Interestingly, mutations that eliminate PI(4)P-phosphatase 
activity of hSAC1 (hSAC1-C/S mutant) also result in an accumulation of this 
phosphatase at Golgi membranes though the putative COPI binding motif (KEKID) is 
present in the phosphatase-dead mutant. This observation suggests that efficient COPI 
interaction is coupled to lipid phosphatase activity. Furthermore, hSAC1 also relocates 
from the ER to the Golgi complex in response to serum starvation (Blogoveschenskaya A. 
et al., 2006 manuscript submitted). However, regardless of growth conditions (quiescence 
or normal growth condition), there is a significant portion of hSAC1 that is always 
present at the Golgi apparatus. This indicates that hSAC1 has important “house-keeping” 
or constitutive functions at the Golgi complex.   
Confocal immunofluorescence studies of hSAC1 and different Golgi markers 
clearly show that hSAC1 is distributed throughout the Golgi complex. hSAC1 co-
localizes equally well with the cis- (p24), medial- (mannosidase II), and trans-Golgi 
(galactosyltransferase (GalT) and TGN46) markers. However, further studies using 
immunogold-labeling and electron microscopy demonstrate that hSAC1 and PI(4)P 
localize to different Golgi regions. hSAC1 was found mainly at the cis- and medial Golgi 
cisternae while the PI(4)P probe Fapp1-PH localize to the TGN (Godi et al., 2004). Only 
under conditions where the Fapp1-PH domain is highly overexpressed, some hSAC1 is 
found to be localized at the same cisternae membrane. Overall, however, overexpression 
of Fapp1-PH domain causes formation of aberrant membrane networks that are distinct 
from hSAC1 positive membranes. The ability of Fapp1-PH domain to induce formation 
of membrane network could be due to overexpressed Fapp1-PH domain bound to PI(4)P 
in a dominant negative way that titrates out Golgi PI(4)P pools. Since PI(4)P is needed 
for anterograde trafficking, accumulation of vesicular-tubular membranes due to 
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inhibition of forward trafficking might lead to formation of these membrane network. In 
fact, Godi A. et al. found that cells with high expression of Fapp1-PH domain showed a 
marked delay in transport of ts045-VSV-G from the TGN to the plasma membrane (Godi 
et al., 2004). Taken together, these findings indicate that the Golgi apparatus is polarized 
by an opposing gradient of PI(4)P at the TGN and a concentration of hSAC1 PI(4)P-
phosphatase at the cisternal Golgi compartments.   
 
4.2: hSAC1-defined functional PI(4)P-depleted regions in the Golgi that are 
important for recycling of resident Golgi enzymes 
 Several reports have demonstrated that PI(4)P functions as an anterograde 
trafficking signal at the Golgi complex (Hama, Schnieders et al. 1999; Schorr, Then et al. 
2001; Wang, Wang et al. 2003; Godi, Di Campli et al. 2004). Recruitment of adaptor 
proteins such as the adaptor protein 1 (AP1) is mediated by the PI(4)P generated by 
PI4KIIα (Wang et al., 2003). In addition, formation of large pleiomorphic carriers (LPCs) 
at the TGN is facilitated by the recruitment of Fapp proteins via PI(4)P synthesized by 
PI4KIIIβ (Godi, 2004). These PI(4)P pools at the Golgi are also controlled by hSAC1 
phosphatase. This study provides evidence that hSAC1 is not only required for temporal 
termination of PI(4)P but it is also a spatial regulator that functions in maintaining 
regions in the Golgi that are devoid of PI(4)P. We found that hSAC1 is responsible for 
creating PI(4)P-depleted Golgi regions that are important for segregating anterograde 
transport from retrograde trafficking of Golgi resident enzymes. PI(4)P defines Golgi 
regions active in secretory cargo trafficking. Cis- and medial- Golgi enzymes are 
excluded from these areas, thus preventing their anterograde escape to the cell periphery. 
However, there has to be some close contact between PI(4)P-enriched and PI(4)P-
depleted domains because cargo passing through the Golgi has to have access to the 
processing enzymes.  
 The distinctive feature of hSAC1 depleted cells is mislocalization of Golgi 
resident enzymes such as ManII and NacT1 to the cell periphery. Besides cell surface 
localization, both enzymes are found in diffused-vesicular like structures. These could be 
internalized cell surface localized enzymes to endosomal compartments. In most cases, 
when we observe cell surface staining of ManII and NacT1, the Golgi is still intact as 
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determine by co-staining with another Golgi marker, TGN46 and p58k (data not shown).  
This observation is distinct from that of depletion of the Golgi localized PI4- kinases. The 
PI4KIIα depleted cells show expanded Golgi with TGN46 staining is more punctate and 
or tubular compared to control cells. Overexpression of a dominant negative kinase dead 
mutant of PI4KIIIβ (D656A) causes a disorganized, filamentous/punctate Golgi structure 
as stained by a Golgi marker, giantin. 
 A spatially restricted PI(4)P gradient in the Golgi (highly concentrated at the TGN 
but not in other Golgi cisternae) is achieved by local recruitment of the PI 4-kinases and 
the presence of the PI(4)P-phosphatase, hSAC1 at this compartment. This is important to 
ensure that PI(4)P is only highly concentrated in regions where anterograde transport of 
cargo takes place, such as at the TGN, where the main sorting events and transport carrier 
formation are carried out. Furthermore, evidence suggests that there are different 
functional subdomains at the TGN that are orchestrated by PI(4)P and other 
phospholipids (Godi A., 2004). Fapp2, OSBP and CERT each contain a common Golgi 
targeting N-terminal PH-domain that targets them to the PI(4)P-enriched TGN while their 
distinctive lipid-binding properties enable a differential localization of these proteins to 
separate TGN domains. Thus, protein targeting via recognition of different lipid signals 
that are created at specific membranes may contribute significantly to how different 
transport events or cellular processes can be separated (for example, anterograde 
transport versus retrograde transport for Golgi enzyme recycling) or integrated (for 
example, recruitment of Fapps at the TGN coupled to formation of transport carriers and 
forward transport via microtubules). 
The idea of functional membrane domains defined by differential localization of 
kinases and phosphatases is consistent with previous reports (Martin, 1997). A recent 
study by Tahirovic et al. had demonstrated that yeast Sac1p is required for confining 
PI(4)P-dependent reactions to specific intracellular membrane compartments (Tahirovic 
et al., 2005). In S.cerevisiae, a sac1 null mutant showed accumulation of PI(4)P at 
different intracellular membranes, which are normally devoid of PI(4)P. Such 
deregulation of intracellular PI(4)P pools leads to defects in vacuolar morphology and 
endosomal trafficking (Tahirovic et al., 2005). Similarly, in hSAC1-depleted cells, we 
find accumulation of PI(4)P. Although the accumulation of PI(4)P in hSAC1 siRNA 
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treated cells is less dramatic compared to the yeast null mutant, it is sufficient for causing 
mislocalization of Golgi resident enzymes and aberrant Golgi morphology. Intracellular 
localization of  PI(4)P, detected by specific antibodies in both control and hSAC1-
depleted cells reveal differences in terms of signal strength and compartments stained by 
the antibody. We find PI(4)P to be accumulated at the Golgi, plasma membrane and 
vesicular-like structures in hSAC1-depleted cells while the control cells display only a 
defined PI(4)P staining to Golgi-like structures.  
To directly show that PI(4)P-phosphatase activity of hSAC1 is responsible for 
maintaining PI(4)P-depleted Golgi regions, we compare PI(4)P staining in wild type and  
phosphatase-dead mutant hSAC1-C/S. We found a drastic difference in co-localization 
studies. The active PI(4)P-phosphatase hSAC1 was localized to PI(4)P-depleted Golgi 
regions. Conversely, the phosphatase-dead hSAC1-C/S mutant co-localized almost 
completely with PI(4)P. This strongly suggests that the lipid phosphatase activity of 
hSAC1 is needed to create PI(4)P-depleted Golgi regions. The importance of a 
functionally active hSAC1 could be further demonstrated in subsequent rescue 
experiments (cell surface biotinylation of NacT1GFP and immunofluorescence staining 
of ManII in hSAC1-depleted cells). Only the ectopically expressed RNAi-resistant wild 
type hSAC1 could reverse the abberant Golgi structure and mislocalization phenotype of 
ManII and NacT1. The RNAi-resistant phosphatase dead mutant, GFP-hSAC1-C/S*, did 
not rescue this phenotype. 
How resident Golgi enzymes are partitioned and maintain their proper localization 
in Golgi cisternae remains a fundamental question in cell biology. Efforts to identify 
common targeting motifs in different Golgi resident enzymes have not been successful in 
explaining the asymmetric distribution of glycosyltransferases (Colley, 1997; Colley, 
1997). The oligomerization/aggregation model and membrane thickness model, which 
are based on vesicular transport static model, have only partially explained how retention 
of Golgi glycosyltransferases might happen. In contrast, the maturation model which 
predicts Golgi as a highly dynamic entity proposes that active retrieval of resident Golgi 
enzymes by COPI vesicles is fundamental for keeping the Golgi glycosyltransferases in 
place. Regardless of the intra-Golgi trafficking models, both vesicular and maturation 
models suggest a role of COPI retrograde vesicles in maintainance of Golgi homeostasis 
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and retrieval of Golgi resident enzymes. We propose that Golgi phosphoinositides (in 
particular PI(4)P) play a fundamental role in organizing this organelle. The fact that large 
amounts of COPI interact with hSAC1 (Rohde et al., 2003), indicates that COPI-
mediated retrieval of Golgi resident enzymes might preferentially occur at low PI(4)P 
Golgi regions created by hSAC1. The escape of resident Golgi enzymes from the Golgi 
to the cell periphery in hSAC1 knock down cells supports this idea. Thus, it is possible 
that the phosphatase activity of hSAC1 in depleting PI(4)P at specific Golgi regions is 
coupled to the formation of COPI retrograde vesicles. To further test this hypothesis, one 
would have to study the dynamics of fluorescently labeled COPI vesicles in cells 
depleted of  hSAC1 using live cell imaging technique. In addition, the localization of 
COPI in hSAC1-depleted cells could be studied via immunostaining and fluorescent 
microscopy in addition to biochemical approaches such as cell fractionation. Analyzing 
phosphoinositide profiles of COPI vesicles in hSAC1-depleted cells might shed light on 
the possible role of lipid microdomains in the formation of COPI vesicles. 
Figure 4.1 shows a schematic illustration of lipid phosphatase hSAC1 in 
maintaining PI(4)P-depleted Golgi regions for proper recycling of Golgi resident 
enzymes such as the Man II and NacT1.  
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Figure 4.1: hSAC1 creates PI(4)P-depleted Golgi regions which are important for retrieval of Golgi 
resident enzymes such as mannosidase II (ManII) and N-acetylglucosaminyltransferase I (NacT1) 
COPII vesicles mediate transport of cargo from ER to Golgi while COPI vesicles are important for retrieval 
of Golgi resident enzymes. hSAC1 is concentrated at the Golgi cisternae while PI(4)P (anterograde 
transport signal) is highly enriched at the TGN. The opposing gradient of PI(4)P and hSAC1 is vital for 
segregating anterograde and retrograde transport events.  
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4.3: The PI(4,5)P2 5-phosphatase OCRL1 and its splice variants 
 The interest in studying the function of OCRL1 has been intensified since the 
discovery of a direct link between the Lowe syndrome and mutations of a PI(4,5)P2 5-
phosphatase (Attree et al, 1992). How mutations in OCRL1 cause progressive multiple 
tissue dysfunctions in  Lowe syndrome patients remains unclear. A failure to phenocopy 
Lowe syndrome in OCRL1 knockout mice (Janne, Suchy et al. 1998) further emphasizes 
the importance of studying the compartment specific function of this lipid phosphatase in 
tissue culture cells in order to dissect the intracellular molecular events governed by 
OCRL1. 
 OCRL1 has two tissue-specific splice variants, designated as isoform-a (OCRL1-a) 
and –b (OCRL1-b) (Lowe, 2005). Both isoforms are ubiquitously expressed with 
OCRL1-b being the predominant isoform expressed in all tissues with the exception of 
the brain. Interestingly, brain cells only express the longer version. The difference 
between these two isoforms is the presence of an additional 8 amino acids in OCRL1-a. 
These 8 amino acids form an acidic cluster that might contain specific binding motifs for 
other proteins (Introduction, Figure 2.7). This acidic cluster resembles phosphofurin 
acidic cluster sorting proteins (PACSs) or Golgi-localizing, gamma-adaptin ear homology 
domain Arf-binding proteins (GGAs) binding sites. To study the isoform-specific 
function of OCRL1, we generated antibodies that recognize only OCRL1-a and examined 
intracellular localization of OCRL1-a in comparison to OCRL1-b. We found that 
OCRL1-b (which lacks the 8 amino acid sequence) was localized predominantly at the 
TGN and early endosomes as shown by co-localization studies using a TGN marker, 
TGN46 and an early endosome marker, EEA1. This is consistent with studies that 
demonstrate that OCRL1 associates with clathrin-positive endosomes that contain 
mannose-6-phosphate receptors (M6PRs) and transferrin (Tf) (Ungewickell et al., 2004; 
Choudhury et al., 2005). In contrast, OCRL1-a showed distinct localization from 
OCRL1-b. Immunofluorescence studies using antibody specific to OCRL1-a showed that 
the isoform-a was absent from perinuclear Golgi but localized to punctate structures. 
These structures did not colocalize with EEA1 but showed partial overlap with a late 
endosomal/lysosomal marker, lamp2. Although the lysosomal localization of OCRL1 has 
been reported (Zhang, Hartz et al. 1998), isoform specific localization of OCRL1 is novel. 
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The distinct localization of OCRL1 splice variants indicates that both isoforms might 
regulate different trafficking routes and have compartment specific functions. However, 
different splice variants of OCRL1 may be involved in different sorting steps involving 
clathrin-binding because both isoforms contain the clathrin-binding site LIDLE. Much 
work is needed to study the splice variant- specific function of OCRL1. 
 The Golgi localization of OCRL1 had been firmly established in different cell 
lines (Suchy, Olivosglander et al. 1995; Dressman, Olivos-Glander et al. 2000). To 
determine whether turnover of Golgi  PI(4,5)P2 by OCRL1 is coupled to PI(4)P 
metabolism by the PI(4)P-phosphatase hSAC1, we first localized both enzymes by 
immunostaining and confocal fluorescence microscopy study. We found that hSAC1 and 
OCRL1 populate different regions of the Golgi. OCRL1 was found preferentially in 
hSAC1-free Golgi regions that were highly enriched with PI(4)P, as determined by co-
localization studies using Fapp1-PH domain and PI(4)P antibody. In addition, we 
silenced the expression of OCRL1 by RNAi and found that OCRL1 depletion had no 
effect on Golgi morphology or caused a  mislocalization phenotype as observed in 
hSAC1-depleted cells. In contrast, knock down of OCRL1 caused defects in bulk 
anterograde secretion. Thus, hSAC1 and OCRL1 seem to play distinct roles in 
maintaining Golgi functions. The turnover of PI(4,5)P2 at the Golgi complex is highly 
dynamic. Visualizing PI(4,5)P2 using specific PI(4,5)P2 binding domains fused with GFP 
or via a specific PI(4,5)P2 antibody could not localize this phospholipid at the Golgi. 
Therefore, OCRL1 5-phosphatase activity might be required for converting the PI(4,5)P2 
signal to PI(4)P signal which is required for anterograde traffic. 
 The main unresolved question regarding Lowe syndrome is how an ubiquitously 
expressed lipid phosphatase could lead to tissue specific manifestations of complex 
phenotypes. More importantly, what is the functional relevance of  the OCRL1 splice 
variants. To address this, one possibility is to selectively knock down the different 
isoforms of OCRL1 using RNAi and study intracellular trafficking events that might be 
governed by OCRL1. It is plausible that specialized cells in affected organs such as the 
lens epithelia cells, or the kidney proximal tubule cells require a functional OCRL1 for 
efficient and proper trafficking and recycling of cell surface membrane proteins. 
Elucidation of the function of OCRL1 splice variants in kidney proximal tubule cells is 
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attractive since one of the hallmarks of Lowe syndrome is Fanconi syndrome, which is a 
defect in solute and protein reabsorption in the proximal tubule (Lowe C.U., et al., 1952, 
Nussbaum R. et al., 2001). Recent finding of a Dent’s disease patient with a mutation in 
OCRL1 further strengthens the notion that defective endosomal transport of 
transporter/channel might be involved in the development of progressive kidney failure 
(Hoopes, Shrimpton et al. 2005). Dent’s disease is typically caused by defective 
endosomal chloride channel, CLC-5. Investigation in membrane trafficking, particularly 
clathrin-mediated transport from TGN to endosomal membranes, using fluorescent-
tagged kidney transporters such as the CLC-5 and other transporters in proximal tubule 
cells may shed light on how dysfunction of OCRL1 causes Fanconi syndrome, one of the 
manifested symptoms in Lowe patients.  
 In conclusion, hSAC1 and OCRL1 are two functionally distinct lipid 
phosphatases that play important roles in regulating phosphoinositides at the Golgi 
complex. The separation of PI(4)P and PI(4,5)P2 pools at Golgi membranes appears to be 
an important mechanism for organizing structurally and functionally distinct Golgi 
regions. Interplay between these two phosphatases tightly and spatially regulate the levels 
of both PI(4)P and PI(4,5)P2. hSAC1 and OCRL1 establish separate phosphoinositide-
specific domains within the Golgi, that are instrumental for segregation of anterograde 
trafficking from the recycling of resident Golgi enzymes.  
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5 Materials and Methods 
5.1: Materials 
5.1.1: Materials used in Heidelberg 
All standard chemicals and reagents were purchased from either Merck 
(Darmstadt, Germany) or Sigma-aldrich Chemie Gmbh (Deisenhofen, Germany). 
Nitrocellulose-Filter (BA85), Whatman 3MM from Schleicher and Schuell GmbH 
(Dassel, Germany). Acylamide solution from National Diagnostics (Atlanta/GA USA); 
prestained protein marker (broad range) from New England Biolabs GmbH 
(Schwalbach/Taunus, Germany); TEMED and skim milk powder from Fluka (Neu-Ulm, 
Germany). X-OMAT AR film from Kodak (Rochester, USA). Other kits used were 
Nucleobond AX100-2000 from Macherey-Nagel (Dueren, Germany); QIAquick PCR 
Purification Kit, QIAquick Gel Extraction Kit and QIAprep Spin Mini Prep Kit from 
Qiagen (Hilden, Germany). Tissue culture medium, Dulbecco’s Minimum Essential 
Media (DMEM), fetal bovine serum (FBS), ampicilin and Lipofectamine/Plus 
transfection reagent were perchased from Invitrogen. 
 
5.1.2: Materials used in Portland 
All standard chemicals and reagents were purchased from either Sigma-Aldrich 
(Saint Louis, MO, USA), Fischer Scientific (Hampton, NH, USA), ISC Bioexpress 
(Kaysville, UT, USA) or VWR (West Chester , PA, USA). QIAquick PCR Purification 
Kit, QIAquick Gel Extraction Kit and QIAprep Spin Mini Prep Kit from QIAGEN 
(Valencia, CA, USA); GenElute Plasmid Miniprep and Maxiprep Kits from Sigma-
Aldrich (Saint Louis, MO, USA); X-OMAT AR Filme from Kodak (Rochester, USA); 
GeneMate BlueAutoradiography Film from ISC Bioexpress (Kaysville, UT, USA); 
Nitrocellulose-filter (BA85) and Whatman 3MM from Fischer Scientific, EcoLume and 
EcoLight(+) scintillation liquid from MP Biomedicals; EZ-Link Sulfo-NHS-LC-Biotin 
(PIERCE) (Rockford, USA). 3H-Thymidine, 3H-myo-inositol, 35S-Methionine/Cystein 
were from Perkin Elmer (Wellesley, MA, USA). Cell culture media DMEM, Trypsin-
EDTA, Dulbecco’s phosphate buffer saline (D-PBS) were from Sigma-Aldrich; OPTI-
MEM Reduced-Serum Media, Lipofectamine/Plus and Lipofectamine 2000 from 
Invitrogen; FBS and New Born Calf Serum from Hyclone, Fischer Scientific.
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5.1.3: Primers and oligonucleotides 
Heidelberg: 
Primers and oligos were synthesized by MWG Biotech (Ebersberg, Germany) and 
Biospring (Frankfurt, Germany). 
Portland: 
All oligos and primers were purchased from Operon (Huntsville, AL, USA).  
 
Sequencing primers for TOPO-TA cloning: 
PCR_Sac1a (Forward):  
5’- GCCAGTGTGCTGGAATTCGCCCTT – 3’ 
PCR_Sac1b (Reverse): 
5’- TGATGGATATCTGCAGAATTCGCC – 3’ 
 
For the generation of ∆NhSAC1(501-587)pEGFPC2  and ∆NhSAC1(512-
587)pEGFPC2 N-terminal deletion mutants: 
Sac1a: 
5’- TGC AGA TCT ATT CAG TGG ATG AAT TAG AAT – 3’ 
Sac1b: 
5’- TGC AGA TCT TAA GTG TTC CAA GGG ACT GG – 3’   
Sac1c: 
5’- GGA CTG CAG TCA GTC TAT CTT TTC TTT CTG G – 3’  
 
Oligos for the generation of RNAi resistant plasmids: 
GFP-hSAC1*: 
GFP-hSAC1*forward:  
5’- GGCAAACCAGGAAGGGGTCTTCCGGAGTAACTGCATGGATTGTC -3’  
GFP-hSAC1* reverse: 
5’- GACAATCCATGCAGTTACTCCGGAAGACCCCTTCCTGGTTTGCC -3’ 
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GFP-hSAC1-C/S*: 
GFP-hSAC1-C/S* forward: 
5’- GGCAAACCAGGAAGGGGTCTTCCGGAGTAACAGCATGGATTGTC-3’ 
GFP-hSAC1-C/S* reverse: 
5’- GACAATCCATGCTGTTACTCCGGAAGACCCCTTCCTGGTTTGCC-3’ 
 
Primer for sequencing of the mutagenized GFP-hSAC1* and GFP-hSAC1-C/S*: 
5’- CCATAAGGAATGTAAAAATATGAGATG-3’  
Primer for sequencing of the RNAi constructs: 
5’-AAT ACG TGA CGT AGA AAG TA-3’ 
 
Oligos for the generation RNAi constructs: 
hSAC1 RNAi plasmids: 
Construct I: 
5’-TCGAGGGCGTGTTCCGAAGCAATTTTCAAGAGAAATTGCTTCGGA 
ACACGCCTTTTT-3’   
5’- CTAGAAAAAGGCGTGTTCCGAAGCAATTTCTCTTGAAAATTGCTT 
CGGAACACGCCC-3’ 
 
Construct II: 
5’-TCG AGC TTC AGA GAC TAG GAG TTT TTC AAG AGA AAA CTC CTA GTC 
TCT GAA GTT TTT-3’ 
5’-CTA GAA AAA CTT CAG AGA CTA GGA GTT TTC TCT TGA AAA ACT CCT 
AGT CTC TGA AGC-3’ 
 
hSAC1 RNAi Control plasmid: 
5’-TCG AGA GCG TGG TCC GAA GCC ATT TTC AAG AGA AAT GGC TTC GGA 
CCA CGC TTT TTT-3’ 
5’-CTA GAA AAA AGC GTG GTC CGA AGC CAT TTC TCT TGA AAA TGG CTT 
CGG ACC ACG CTC-3’ 
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OCRL1 RNAi constructs: 
Construct A: 
5'-TCGAGGATAGTGTACGCATCATGGTTCAAGAGACCATGATGCGTACAC 
TATCTTTTT-3' 
5'-CTAGAAAAAGATAGTGTACGCATCATGGTCTCTTGAACCATGATGCGT 
ACACTATCC-3' 
 
Construct B: 
5'-TCGAGGACAGACTCCAAGTGACCGTTCAAGAGACGGTCACTTGGAGTC 
TGTCTTTTT-3' 
5'-CTAGAAAAAGACAGACTCCAAGTGACCGTCTCTTGAACGGTCACTTGG 
AGTCTGTCC-3' 
 
Construct C: 
5'-TCGAGGCAGACGATCTCGGGCTCCTTCAAGAGAGGAGCCCGAGATCGT 
CTGCTTTTT-3' 
5'-CTAGAAAAAGCAGACGATCTCGGGCTCCTCTCTTGAAGGAGCCCGAGA 
TCGTCTGCC-3' 
 
Constrol OCRL1 construct: 
5'-TCGAGCATCGTGTCCGCATCACGGTTCAAGAGACCGTGATGCGGACAC 
GATGTTTTT-3' 
5'-CTAGAAAAACATCGTGTCCGCATCACGGTCTCTTGAACCGTGATGCGG 
ACACGATGC-3' 
 
siRNAs sequences: 
OCRL1 siRNA duplex (siOA): 
Forward: 
5’- GAU AGU GUA CGC AUC AUG G tt –3’ 
Reverse complement : 
5’- C CAU GAU GCG UAC ACU AUC tt –3’  
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OCRL1 Control siRNA  duplex (siOCtr): 
Forward : 
5’- CAU CGU GUC CGC AUC ACG G tt –3’  
Reverse complement : 
5’- C CGU GAU GCG  GAC ACG ATG  tt -3’  
 
hSAC1 siRNA duplex (siA): 
Forward : 
5’- GGC GUG  UUC  CGA AGC AAU U tt –3’   
Reverse complement : 
5’- A AUU GCU  UCG GAA CAC GCC tt –3’ 
 
hSAC1 Control siRNA duplex(siCtr): 
Forward : 
5’-  AGC GUG GUC CGA AGC CAU U tt –3’ 
Reverse complement : 
5’-  A AUG GCU UCG GAC CAC GCU tt-3’ 
 
5.1.4: Plasmids and constructs 
Vectors: 
pCDNA3.0 (Invitrogen): 
Eukaryotic expression vector for constitutive expression; contains CMV promoter and T7 
promoter, neomycin resistance cassette 
 
pCRII_TOPO (Invitrogen): 
TOPO-cloning vector for “TA-cloning” of PCR products, contains T7 promoter and SP6 
promoter.  
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pEGFPC1 and pEGFPC2 (Clontech): 
pEGFPC1 and pEGFPC2 each encode the green fluorescence protein GFPmut1 variant 
which contains the double-amino-acid substitution of Phe-64 to Leu and Ser-65 to Thr. 
Genes cloned into the multiple cloning sites (MCS) will be expressed as fusions to the C-
terminus of EGFP if they are in the same reading frame as EGFP. A Neomycin resistance 
cassette (NeoR), consisting of the SV40 early promoter, the neomycin/kanamycin 
resistance gene of Tn5 and polyadenylation signals from Herpes simplex virus thymidine 
(HSV TK)kinase gene allows stably transfected eukaryotic cells to be selected for using 
G418. 
 
pSuppressorNeo (from Gene Supressor System; IMGENEX Corporation) :  
Linearized plasmid vector (digested with SalI and XbaI) for cloning of the annealed 
oligos containing an 5’-XhoI (forward strand oligo) and an XbaI overhang of the 5’-
reverse oligo. It contains a U6 promoter for expression of the siRNAs. Contained a 
Neomycin/Kanamycin resistance cassette (Neo/KanR) 
 
GFP-hSAC1:  
Full length wild type hSAC1 was obtained from pYEX_BX_hSAC1wt (Rohde et al., 
2003) using BamHI restriction digest and cloned in frame into pEGFPC1. This resulted in 
an N-terminally tagged GFP-hSAC1. 
 
GFP-hSAC1-C/S: 
GFP-tagged N-terminally hSAC1 phosphatase dead mutant (Rohde et al., 2003) 
 
∆NhSAC1(501-587)pEGFPC2  
hSAC1 N-terminal-deleted mutant fused with GFP at its N-terminus. Primer Sac1a and 
Sac1c were used in PCR to generate a 314bp fragment. PCR fragments were cloned into 
pCRII_TOPO vector and subcloned into pEGFPC2 using BglII and PstI restriction sites.  
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∆NhSAC1(512-587)pEGFPC2 
N-terminal deletion mutant of hSAC1. Primer Sac1b + Sac1c were used in PCR to 
generate a 254bp fragment. Plasmid was generated as described in ∆NhSAC1(501-
587)pEGFPC2  
 
GFP-OCRL1-b 
A kind gift from Martin Lowe (Choudhury, Diao et al. 2005) 
 
pBB3: 
Plasmid containing the 5’-end of the RedStar2 sequence fused with the Myc-Fapp1-PH 
domain and cloned into pcDNA3.0(-) (generated by Ben Brankatschk) 
  
pBB2:  
Plasmid containing the 5’-end of the GFP sequence fused with the Myc-Fapp1-PH 
domain and cloned into pcDNA3.0(-) (generated by Ben Brankatschk) 
 
NacT1GFP: 
Amino acid (1-103) of  NacT1-Myc-GFP cloned into PCNG2 (a kind gift from Dave 
Shima) 
 
hSAC1 RNAi resistance plasmids: 
Both GFP-hSAC1* and GFP-hSAC1-C/S* were generated from the original template 
plasmids: GFP-hSAC1 and GFP-hSAC1-C/S using the QuickChange II Site-directed 
Mutagenesis kit (Stratagene). 
 
pECFP-Golgi (human beta 1,4-galactosyltransferase) (CLONTECH): 
Encodes a fusion protein consisting of enhanced cyan fluorescent protein (ECFP) and a 
sequence encoding the N-terminal 81 amino acid of human beta 1,4-galactosyltransferase. 
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5.1.5:Peptides used for generating hSAC1 antibody 
Table 5.1: Peptide sequence for generating hSAC1 antibody 
Peptide used Peptide sequence 
hSAC1A (#66) C QLQDNKTFLAML   
hSAC1 B (#67) C DGFQRHFDSQVI    
hSAC1 C (#68) C TRTGKRTHLGLI 
hSAC1 D (#69) 
 
C NGKDFVDAPRLVQKEKID 
 
5.1.6 : Enzymes and kits 
Heidelberg : 
Restriction enzymes, alkaline phosphatase and T4-DNA ligase and the corresponding 
buffers were purchased from New England Biolabs GmbH (Schwalbach/Taunus, 
Germany) or Roche Diagnostics GmbH (Mannheim, Germany), Taq polymerase was 
from TaKaRa (Shiga, Japan). 
 
Portland: 
Restriction enzymes, alkaline phosphatase, T4-DNA ligase, Taq polymerase and the 
corresponding buffers were purchased from New England Biolabs (Beverly, MA, USA) 
or Roche Diagnostics GmbH (Indianapolis, IN, USA); 100bp-DNA marker from New 
England Biolabs and 1kb-DNA marker from ISC Bioexpress. Kits used were Gene 
Supressor System (IMGENEX Corporation) (Cat#: IMG-800); Mini and Maxipreps kits 
(SIGMA); TOPO TA Cloning Kit (Invitrogen);Quick Change Mutagenesis (Qiagen); 
QIAquick Gel Extraction kit (Qiagen); Phosphatase, alkaline (calf intestine) (Roche); T4 
Phage Ligase (Roche); ECL solution (Milipore); ProLong Antifade Kit (P-7481) 
(Molecular Probes) 
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5.1.7: Cell culture media, transfection reagents and cell lines 
Dulbecco’s Minimum Essential Media (DMEM), L-glutamine, DMEM 
(Cystein/Methionine free), Fetal Bovine Serum and New Born Calf Serum were from 
Hyclone; Gentamycine, Trypsine/EDTA and D-PBS (-Ca2+ &-Mg2+) were purchased 
from SIGMA. OPTI-MEM Reduced Serum Media, Lipofectamine/ Plus reagent and 
Lipofectamine 2000 were purchased from Invitrogen. 
 
Tissue culture cell lines used : 
(1) Hela cells 
Human cervical cancer cell line containing the E6 and E7 genes of the human 
papillomavirus 18 integrated into the genome.  
(2) HEK293 cells 
HEK 293 cells were generated by transformation of human embryonic kidney cell 
cultures (hence HEK) with sheared adenovirus 5 DNA. 
(3) COS7 cells 
Cercopithecus aethiops kidney cell line, transformed with SV40 large T antigen 
(3) NIH-3T3 cells 
Mouse fibroblast cell line 
 
5.1.8: Fixatives used for immunogold EM sample preparation  
(1) 8% EM grade glutaraldehyde from Polyscience (Cat.00216) 
(2) 10% paraformaldehyde freshly prepared from paraformaldehyde (Sigma P1213) 
Preparation of 10% stock solution of paraformaldehyde in aqua dest: 
10 g paraformaldehyde were added to 75 ml aqua-dest (demi-water). Place the 
solution “au bain marie” (in another beaker with hot water) on a combined stirrer/heater 
in the hood. The temperature of the water bath should not exceed 60oC. The solution was 
kept at 55 oC  to 58 oC under constant stirring until all paraformaldehyde had dissolved. 
Add 0.1 M NaOH to solution to get the final pH of the fixative to pH 7.0. Aqua dest was 
added to an end volume of 100 ml and filtered using whatman paper on a funnel and 
finally stored in aliquots in the -20 oC freezer. Upon thawing the solution would remain 
white until cleared in hot. If it did not get clear, it was not used.  
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Stock-solution of 0.2 M phosphate buffer: 
Buffer A: NaH2PO4.1H20 = 27.6 g in 1000 ml aqua dest 
Buffer B: Na2HPO4.7H20 = 53.65 g or 
  Na2HPO4.2H2O = 35.6 g or 
  Na2HPO4.12H20 = 71.7 g in 1000 ml aqua dest. 
 
Add 19 ml buffer A to 81 ml buffer B to get 0.2 M phosphate buffer, pH7.4. Check pH 
and if necessary add more of the appropriate buffer to get pH7.4 
 
 
 
5.1.9: Antibodies 
5.1.9.1: Primary antibodies 
Table 5.2: Primary antibodies used and their tested applications  
Antibodies Raise in dilution source 
α-hSac1(#69) Rabbit IF 1:100  
WB 1:7500  
Self-made in ZMBH
α-PI4P Mouse IF 1:100-1:250 Echelon 
α-Mannosidase II Rabbit IF 1:1000 
WB 1:500  
Complex 
Carbohydrate 
Centre University of 
Geogia 
α-Mannosidase II Mouse IF 1:100  Chemicon 
α-TGN46 Sheep IF 1:1000 Serotec 
α-p24 “Elfriede” Rabbit IF 1:200 Felix-Wieland, 
BZH, Heidelberg. 
p58k (clone 58k-9) Mouse IF 1:100 SIGMA 
α-Sec61β Rabbit IF 1:100 
WB 1:10 000  
Benhard 
Dobberstein, 
ZMBH, Heidelberg 
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α-OCRL1 Mouse IF 1:50  
WB 1:400  
Sharon F. Suchy, 
NIH  
α-OCRL1 isoform a 
 
α-OCRL1 isoform a 
& b 
 
Rabbit 
 
Guinea Pig 
 
WB 1:10000  
 IF 1:50 
WB 1:500 
IF 1:50 
 
Tailer-made; 
GeneMed 
L23a Rabbit WB: 1: 5000 
 IP: 1:50 
Benhard 
Dobberstein, 
ZMBH, Heidelberg 
Sec61α Goat WB 1:100-1:1000 
 IF 1:100 
SantaCruz  
GFP (FL) Rabbit WB 1:1000 Santa Cruz 
GFP Rabbit WB 1: 10 000 Dirk 
Gorlich,ZMBH, 
Heidelberg 
GAPDH Mouse WB 1: 100 000 Abcam 
MHC-I Mouse 
Clone W6/32 
IP 1:500 
WB 1:5000 
Klaus Früh,  
VGTI,OHSU West 
campus, Portland, 
OR 
PARP Mouse 
Clone C2-10 
WB 1.5000 BD Biosciences 
Pharmingen 
 
 
5.1.9.2: All secondary antibodies (coupled to fluorophore or HRP-coupled) were 
purchased from Jackson Immunoresearch. 
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5.1.10: Common buffer stocks and solutions 
(1) 1x SDS-PAGE running buffer 
1.44% glycine, 0.3% Tris-base, 0.1% SDS 
(2) Ponceau S  
0.2% ponceau S in 3% Trichloroacetic acid (TCA) 
(3) 20 X PBS  
160g NaCl, 4g KCl, 28.8g Na2HPO4, 4.8g KH2PO4 
(4) 1x TAE buffer 
-40mM Tris acetate, 2mM EDTA, pH adjusted to 7.8 using (1N HCl or 1N NaOH 
to adjust) 
(5) 6x DNA loading buffer 
-0.25% bromophenol blue, 0.25% Xylen Cynol blue, 30% glycerol in H2O 
(6) LB media 
-1% (w/v) peptone, 0.5% (w/v) yeast extract, 170mM NaCl and pH adjusted to 
pH7.0 using 5N NaOH 
(7) LB/Amp 
 100µg/ml ampicillin in 1L of LB  
(8) LB/Kan 
50µg/ml kanamycin in 1L of LB 
(9) SOB 
2% (w/v) trypton, 0.5% yeast extract , 10mM NaCl, 10mM MgSO4, 10mM 
MgCl2 and 2.5mM KCl. pH was adjusted to pH7.0 using 5N NaOH. 
 
5.2: Methods 
5.2.1: Methods in Molecular Biology 
Extraction and purification of plasmid DNA from E.coli were performed 
according to the manufacturer’s instructions (SIGMA Maxiprep and Miniprep kits, 
Portland; Nucleobond AX100-2000). All the standard methods of molecular biology that 
were not described in this chaper were performed according to (Sambrook, Fritsch et al. 
1989). 
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5.2.1.1: Ethanol precipitation of plasmid DNA 
1/10 volume of 3M Sodium acetate, pH 5.2 and 3 volumes of 100% Ethanol were 
added to DNA. Solutions were mixed and incubated in -20˚C freezer either overnight or 
1-2 hours before centrifugation at 13,000g for 10min. The resulting DNA pellet was 
washed 2 times with 70% Ethanol. The pellet was then air dried for 5 min and 
resuspended in water or TE buffer. The DNAs were stored at -20˚C. 
 
 
5.2.1.2: Agarose gel electrophoresis 
To separate DNA fragments, 0.8%-2% agarose gels were used depending on the 
fragment size. Agarose was dissolved in 1 X TAE buffer by using a microwave oven. 
1µg/ml ethidium bromide was added to the agarose solution, which was poured into a gel 
chamber. DNA samples were mixed with 6x loading buffer in a ratio of 1:5 before 
loading onto the agarose gel. Electrophoresis was performed in  1 x TAE buffer at 40-
60mAs. 
 
5.2.1.3: DNA Restriction Digests 
For analytical restriction digest of plasmid DNA, 10 units of appropriate 
restriction enzymes were used. 50 units of restriction enzymes were used for preparative 
digestions with starting DNA materials between 5-10 µg. 
For cloning of DNA framents into desired expression vectors, the insert and backbone 
DNAs were digested with the appropriate restriction enzymes for 3 hours or overnight at 
37˚C. The DNA fragments were separated by gel electrophoresis and purified via 
QIAquick gel extraction kit according to the manufacturer’s instructions. 
 
5.2.1.4: Alkaline phosphatase treatment 
Before ligating the digested and gel purified DNA fragments, the vector backbone 
was treated with approx. 5units of Antarctic Phosphatase for 15 min (blunt ends) or 1 
hour at 37˚C. The phosphatase was deactivated at 65˚C for 5 min.  
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5.2.1.5: Ligation 
Ligation was performed using 1 Unit of  T4 ligase (Roche) in 10-20µl reaction. 
Different ratios of vector:insert were set up [1:5, 1:7 and 1:10 (v/v) e.g.1µlVector:5µl 
Insert] and  incubated overnight at 16˚C. The ligation mixture was desalted by using  
nitrocellulose membrane (Milipore) floats on water for 30 min before transforming into 
electrocompetent bacteria cells . 
For cloning of PCR fragments into vector backbones, the TOPO-TA cloning was 
done according to the manufacturer’s instructions. Taq Polymerase generated PCR 
fragments contained single deoxyadenosine overhangs at the 3’- end (dA-3’) while the 
linearized pCRII vector possessed an overhanging deoxythymidine residue (dT-3’). This 
allowed efficient annealing of the PCR fragment to the vector, catalyzed by  
Topoisomerase I which was covalently bound to the vector. For subcloning of the PCR 
fragments into different mammalian expression vectors, appropriate restriction digests 
were performed and fragments were purified as described above. 
 
5.2.1.6: Cloning of RNAi plasmid 
The RNAi constructs were generated using the Gene Supressor System 
(IMGENEX Corporation). Oligos containing a 5’-XhoI site (forward), a 5’-XbaI site 
(reverse complement strand), and inverted repeats of the targeting sequence flanked by a 
6bp spacer were annealed according to the manufacturer’s instructions. The annealed 
oligos were ligated into linearized pSuppressorNeo vector. The ligation product was then 
transformed into competent cells as described in 5.2.1.9. 
 
5.2.1.7a: Polymerase Chain Reaction (PCR) 
For cloning of hSAC1 C-terminal mutants (3-pEGFPC2; 5-pEGFPC2), PCR was 
used to applify the last 254bp and 314bp of the C-terminal of hSAC1. PCR was 
performed using a mixture of Taq and Pfu polymerases. PCR was set up in 50µl reaction 
mixtures as follows: 
50-100ng/µl template DNA (hSAC1wtGFP)   
25pmol/µl 5’- and 3’- primers each 
10mM dNTPs (2mM dNTPs stock) 
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3.2.1.7b: Site-directed mutagenesis 
To generate RNAi resistant plasmid, GFP-hSAC1* and GFP-hSAC1-C/S*, PCRs 
were performed using the PfuUltra high-fidelity (HF) DNA polymerase (2.5U/µl), dNTP 
mix and 10x reaction buffer supplied by the manufacturer (Stratagene). GFP-hSAC1 and 
GFP-hSAC1-C/S were used as templates together with the mutagenesis primers listed in 
5.1.3. Sample reactions were prepared as follow: 
5µl 10 X reaction buffer  
X µl (5-50ng) of dsDNA template 
X µl (125ng) of oligonucleotide forward primer 
X µl (125ng) of oligonucleotide reverse primer 
1 µl of dNTP mix 
ddH2O to final volume of 50µl then add 1µl of PfuUltra HF DNA polymerase 
 
PCRs were performed as follows: 
Segment Cycles Temperature Time 
1 1 95˚C 30s 
2 2-18 95˚C 30s 
  55˚C 1min 
  68˚C 2min/kb of plasmid 
length 
The resulting PCR products were digested with 1µl of DpnI restriction enzyme (10U/µl) 
for 1 hour at 37˚C to digest the parental supercoiled dsDNA. This was followed by 
transformation of XL1-Blue Supercompetent cells/ One short Top 10 cells via chemical 
transformation (5.2.1.9). 
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5.2.1.8: Making of electrocompetent cells 
Electrocompetent E.coli cells were made from DH5-α bacteria (Clontech). A 5ml 
DH5-α bacteria culture was set up in SOB media and incubated overnight at 37˚C. The 
5ml precultured bacteria were added into 500ml SOB the next day and further incubated 
at 37˚C until they reached an OD600nm = 0.4. Cells were pelleted by centrifugation at 3500 
rpm, 4˚C. The resulting pellet was washed 3 times with ice cold 1.4% Glycerol and 
finally resuspended in 2-3 volumes of 15% Glycerol. Cells were aliquoted (120µl) in 
1.5ml tubes and snap frozen using liquid nitrogen. They were then stored at -80˚C.  
The competent bacteria cells were electroporated using an electroporator at the setting of 
2.5kV, 200Ω and 25µF. If the time constant was less than 4.6, the cells were washed 
again with 1.4% Glycerol before storage in the freezer. 
 
5.2.1.9: Transformation of competent cells 
For electroporation of electrocompetent cells, 5-10µl of desalted ligation mixture 
were added to 60µl cell suspension and transferred to a prechilled 4mm-gap cuvette. 
Cells were electroporated at 2.3-2.5kV, 200Ω, 25µF and 250µl of LB or SOC media were 
added to cells. After 1 hour incubation at 37˚C in a shaker, cells were plated on either LB 
Ampicillin or Kanamycin plates and incubated overnight at 37˚C.  
For transformations using chemically competent cells (One shot Top 10 cells, Invitrogen), 
cells were thawed on ice and the ligation mixture was added to 50µl of competent cells. 
Cells were incubated on ice for 30 min before heat-shock at 42˚C for 45s. 200-250µl of 
SOC media was added to cells, which were then incubated for 1 hour at 37˚C, 220rpm.  
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5.2.2: Methods in tissue culture 
5.2.2.1: Cultivation and passaging of mammalian cells 
All cell lines were cultivated using standard tissue culture techniques (according 
to instructions/ protocols at the ATCC website: 
http://www.atcc.org/common/technicalInfo/TechLit.cfm. Experimental work with 
mammalian cell lines was performed in sterile laboratory. Cells were cultured in 5% CO2, 
95% humidify water-jet humudified incubator 37˚C. 
Cells were passaged when they reach confluency between 75-95%. To passage or seed 
cells for experiments, 0.5ml-3ml of  trypsin-EDTA (SIGMA) was added to cells after 1x 
wash with D-PBS (without calcium/magnesium). After a brief incubation at 37˚C, serum-
containing media was added to cells and cells were detached from plates/flasks by 
trituration. For experiments, 15µl of cell suspension were counted in a counting chamber 
(Haemocytometer) and triple values were used to calculate the mean. 
 
5.2.2.2: Freezing and thawing cells 
To preserve cell lines, cells were cultured in a flask until 95% confluency. After 
trypsinization, cells were centrifuged at 1200 rpm and resuspended in 2 ml DMEM 
containing 10% DMSO. 1ml of this suspension was added to each 2ml cryovial (NUNC) 
and stored at -80˚C overnight before long term storage in a liquid nitrogen tank. 
To recover frozen stock, cells were hand warmed and thawed by warming the cyovials in 
a 37˚C water bath. The thawed cell suspension was added to a flask containing 10ml of 
media (at least 10 x volume of the frozen stock). Media was changed after cells were 
attached.  
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5.2.2.3: Transfections using Lipofectamine Plus and Lipofectamine 2000 
Cells were seeded one day before transfection at a density between 2.2x105 to 
10.0x 105 depending on the size of the dishes used for each experiment. Plasmid DNAs 
or siRNAs and transfection reagents (Lipofectamine/Plus or Lipofectamine 2000) were 
diluted in OPTI-MEM reduced serum media in eppendorf tubes according to the 
manufacturer’s instructions. After incubation for 20-25min at room temperature, the 
complexes were added to cells in antibiotic free DMEM or OPTI-MEM. In the case of 
OPTI-MEM, the media was changed 3-6 hours after incubation with serum containing 
DMEM. Cells were assayed at least one or two days post-transfection (for expression of 
GFP-tagged markers in immunofluorescence studies). For experiments using hSAC1 or 
OCRL1 knock down cells, the experiments were only performed on day 3 or day 4 post- 
transfection. 
 
5.2.3: Expression and analysis of proteins in tissue culture cells 
5.2.3.1: Preparation of cell lysates 
In general, two methods were used to prepare cell lysates for SDS-PAGE. For 
pulse-chase and time course experiments (in which immunoprecipitations were 
performed), cells were lysed in 0.5ml (for 6cm-dish) or 1ml (for 10cm-dish) of RIPA 
buffer (1% NP40, 1% Sodium deoxycholate, 150mM NaCl, 50mM Tris pH 8.0). After 
10-15 min incubation on ice, cells were collected in a 1.5ml eppendorf tubes and 
centrifuged at 13,000 x g for 10 min at 4˚C. Supernatants were transferred to new tubes 
and immunoprecipitations were performed. 
Alternatively, cells were trypsinized and 1ml of cell suspension was used. After 
centrifugation at 1200-2000 x g for 2 min, supernatants were discarded and cell pellets 
were resuspended in 2 x LSB and boiled for 5 min. Following 3 min of centrifugation at 
13,000 x g supernatants were loaded onto an SDS-PAGE gel. 
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5.2.3.2: SDS Gel Electrophoresis (SDS-PAGE) 
To separate proteins, SDS-gel electrophoresis was employed according to the 
method of Laemli. 4% stacking and 10% separating gel were used. Polyacrylamide gels 
were made according to the table below: 
 
 4% stacking gel 10% separating gel 
Water (ml) 3 11.2 
2M Tris-HCl, pH 8.8 (ml) - 5 
0.5M Tris-HCl, pH 6.5 (ml) 1.25 - 
37% Polyacrylamide (ml) 0.67 8.3 
10% SDS (µl) 50 250 
10% Ammonium Persulfate 
(µl) 
50 200 
TEMED (µl) 5 20 
 
Protein samples were denatured in Laemli sample buffer (LSB) at 95˚C for 5 min before 
they were loaded on SDS-gel. SDS-PAGE was performed at 50-60mA under ventilation. 
 
To make 50ml of  2x LSB 5x LSB 
1M Tris-HCl, pH=6,8 (ml) 6 15 
Glycerol (ml) 10 25 
Beta-Mercaptoethanol (ml) 5 10 
Bromophenol blue (mg) 1 2 
SDS (g) 2 5 
ddH2O 29 - 
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5.2.3.3: Western blot 
After proteins were separated via SDS-PAGE, they were transferred onto nitrocellulose 
membrane by Western blotting. A Semi-dry blotting appratus was used and Western 
blotting was set up as follows: 
(from Below/on the surface of the apparatus): 
3 Whatman papers soaked in buffer A2 (300mM Tris, 20%(v/v) Methanol) 
3 Whatman papers soaked in buffer A1 (30mM Tris, 20% (v/v) Methanol) 
nitrocellulose soaked in buffer A1 (30mM Tris, 20% (v/v) Methanol) 
SDS-PAGE Gel equilibrated in buffer K (25m Tris, 40mM 6-aminohexanoic acid, 20% 
(v/v) Methanol, 0.01% SDS) 
Finally 3 Whatman papers in Buffer K (25m Tris, 40mM 6-aminohexanoic acid, 20% 
(v/v) Methanol, 0.01% SDS) on top of the gel. 
(Top) 
Western blotting was performed for 1h at 297 mA followed by Ponceau S staining (to 
visualize protein bands on a nitrocellulose membrane). For documentation, the Ponceau S 
stained nitrocellulose was photocopied. The nitrocellulose was then washed with PBS/T 
followed by 1hour blocking in 10% milk/PBST. In some cases, blocking was done 
overnight at 4˚C.  
To detect specific proteins on the membrane, specific antibody against the protein of 
interest diluted in 2% milk/PBST was added to the membrane and incubated either at 
room temperature for 1 hour or overnight at 4˚C on a shaker. The membrane was washed 
for 30 min in PBS/T ( 6 x 5 min PBS/T washes) and further incubated with respective 
secondary antibodies coupled to horse-radish peroxidase (HRP) in 2% milk/PBST. After 
6 x 5 min PBS/T washes, the membrane was incubated with ECL solution (Millipore) for 
5 min and specific protein bands were detected on KODAK film in dark room.  
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5.2.3.4: Immunoprecipitation 
Cell lysates were prepared as Section 5.2.3.1. The lysates were incubated either 
overnight or 1-4 hours at 4˚C with 50% agarose beads/PBS on a rotisserie. After 
preclearance, lysates were incubated with antibodies overnight in the cold room. Either 
50% protein A/PBS or 50% protein G agarose/PBS was added to lysates (depending on 
the source of the primary antibody) and incubated for 1 hour at 4˚C. The agarose beads 
were washed twice with RIPA buffer (1% NP40, 1% Sodium deoxycholate, 150mM 
NaCl, 50mM Tris pH 8.0) before addition of 2 x LSB. Samples were boiled at 95˚C for 5 
min and subjected to SDS-PAGE. 
 
5.2.3.5: Generation of specific antiserum against hSAC1 
Rabbit polyclonal antibodies against hSAC1 (#69) were generated by the 
assistance of animal facilities in the ZMBH, Heidelberg. Peptides were made by Peptide 
Specialty Laboratories Gmbh, Heidelberg. The peptide sequences were listed in Table 
(5.1). Briefly, all 4 peptides were synthesized with a Cystein at the N-terminus. Imject 
Mariculture Keyhole Limpet Hemocyanin (PIERCE) (Cat#: 77600) was coupled to these 
peptides and used for immunization. 4 rabbits were immunized:  
Rabbit #66: Peptide hSAC1 A 
Rabbit #67: Peptide hSAC1 B 
Rabbit #68: Peptide hSAC1 C 
Rabbit #69: Peptide hSAC1 D 
 
5.2.4 : Cell biological, biochemical and molecular biology functional anaysis  
5.2.4.1: Immunofluorescence 
Cells were seeded on round coverslips (Carolina) either after transfections (day 
one post-transfection) or a day before immunostaining. Before addition of fixative, cells 
were washed 2-3 times with PBS. Cells were fixed by 4% paraformaldehyde/PBS or 4% 
formaldehyde/PBS for 15 min at RT. After PBS washes (3-4 times), cells were incubated 
with 100mM Glycin/PBS or 50mM NH4Cl/PBS for 5min and permeabilized using 0.1%-
0.4% TritonX/PBS for 3 min. This was followed by 5 washes with PBS and cells were 
incubated with 1% BSA/PBS for at least 30min – 1hour at RT. Primary antibodies were 
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added to cells and incubated for 1 hour at RT (4˚C for overnight incubation). Cells were 
incubated with secondary antibodies after 5 x 5 min PBS washes. Incubation was carried 
out at RT for 1 hour. For mounting of samples, cells were washed 5 x 5 min with PBS 
and rinsed with water before they were mounted. ProLong Antifade Kit (P-7481) 
(Molecular Probes) was employed to mount samples. Both primary and secondary 
antibodies were diluted in 1% BSA/PBS between 1:100-1:1000 dilution depending on the 
affinity of the antibodies. In general, all secondary antibodies were used in 1:100 
dilutions.  
 
5.2.4.2: Alternative protocol for immunostaining 
After 15-20 min fixation with 4% paraformaldehyde/PBS, cells were washed 
twice and permeabilized using 0.2% Saponin/PBS for 30 min. Cells were then incubated 
with blocking solution (0.2% Saponin, 5% Gelatin in PBS) for 30 min to 1 hour. Both 
primary and secondary antibodies were diluted in blocking solution before added to cells. 
Antibody incubation periods were described as above (5.2.4.1) 
 
5.2.4.3: Staining of phosphoinositides using specific antibodies 
Localization of different phosphoinositide pools can be visualized either by 
ectopic expression of specific phosphoinositide binding domains fused with GFP or GFP 
variants or by specific antibodies against different species of phosphoinositides. To study 
PI(4)P at the Golgi membranes, expression of a Fapp1-PH domain fused with GFP and 
RFP was used. 24-48 hours post-transfection, cells were fixed and visualized under a 
fluorescence microscopy. In colocalization studies, cells were permeabilized as described 
in (5.2.4.1). 
For staining of PI(4)P, cells were fixed with 2% Formaldehyde/PBS for 10 min at 
RT. After 3 washes with PBS, 10µg/ml digitonin in 100mM Glycine/PBS was used to 
permeabilize cells. After 5 min incubation at RT, cells were washed ( 3-5 times) with 
PBS and 1% BSA/PBS was added to cells for blocking. PI4P antibody was diluted in 1% 
BSA/PBS (1.100-1.200) and incubated overnight at 4˚C. Secondary antibody incubation 
was as described in (5.2.4.1). 
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5.2.4.4: Immunofluorescence Microscopy 
siRNA treated  cells were trypsinized and reseeded on glass coverslips. 
Immunofluoresce was performed as described in Rohde H.M. et al, 2003. In brief, cells 
were fixed with 4% Paraformaldehyde, incubated with 0.1M Glycine,  and permeabilized 
with 0.4% Triton X-100. Cells were incubated with respective primary and secondary 
antibodies diluted in PBS containing 1% bovine serum albumin.  
Cells were examined using a Nikon Eclipse E800-microscope equipped with a 
CoolSNAP HQ-Camera from Photometrics (Tuscan, AZ, USA). Confocal micrographs 
were taken by an Olympus BX51-Microscope using an Olympus PlanApo 60 x Oil 
immersion objective. Images were analyzed using Metamorph Image software (for 
fluorescence micrographs) and Image J (Confocal micrographs). 
 
5.2.4.5: Lipid extraction and HPLC analysis 
Cells were labeled with 10µCi/ml [3H]-myo-inositol in inositol-free media (ICN) 
for 48 hours before they were harvested. After washing with ice-cold PBS, 1ml of ice-
cold 0.5M perchloric acid was added to cells and the cells were scraped into an eppendorf 
tube. The resulting pellet was washed once with ice-cold 0.5M perchloric acid, To 
solubilise lipids in the pellet, 750µl of methanol:chloroform:HCl (80:40:1 v/v) was added 
and vortexed briefly (1min). After incubation at room temperature for 30 min, 250µl of 
chloroform and 450µl of 0.1M HCl were added and centrifuged for 1min to separate the 
phases. The lower organic phase was transferred to a new tube and 50µl of 1M 
NH4OH/Methanol was added to the upper aqueous phase to neutralize it. The aqueous 
phase was re-extracted twice with 450µl of synthetic lower phase, [Methanol: 
Chloroform: HCl, 80/40/1]: Chloroform: 0.1M HCl, 3/1/1.8 v/v. The pooled organic 
phase was washed with 5 volumes of 2M KCl, and dried in a speedvac.  
Dried lipid pellet was deacylated by adding 200µl of methlyamine reagent and 
incubated in a sealed tube at 53°C for 30min. The mixture was dried in a speedvac and 
the dried lipid was re-dissolved in 500µl of distilled water and 600µl butan-1-ol: 
petroleum ether: ethyl formate (H2O-saturated), 20/4/1 v/v, vortexed and centrifuged for 
1min. The upper phase was taken off and this step was repeated once with the lower 
   
  5 Materials and Methods 
111 
phase, followed by final extraction with petroleum ether: ethyl formate, 4/1 v/v. The 
lower phase was dried in a speedvac and the pellet was resuspended with 160µl  of 
10mM (NH4)4HPO4. HPLC analysis of glycerophosphoinositols was carried out on a 
Jasco HPLC system equipped with an LB 508 Radioflow detector (Barthold, Bad 
Wildbach, Germany). The following gradient for elution of the HPLC column was used: 
buffer A contained distilled water, buffer B contained 1M (NH4)4HPO4 (pH3.8). The 
gradient was run at 0% buffer B for 10 min and increased to 25% buffer B over 60min 
and 20 min at 0% buffer B.The flow rate was 1ml/min. 
 
5.2.4.6: Cell Surface Biotinylation of NacT1GFP in hSAC1 siRNA treated cells 
Hela cells were plated in 10cm-dishes one day before transfection in antibiotic 
free media. Cells were cotransfected with plasmid expressing NacT1GFP and RNAi 
resistant GFP-hSAC1* or GFP-hSAC1-C/S* together with siRNA directed against 
hSAC1 or a control siRNA using Lipofectamine 2000. 72 hours post-transfection, cells 
were washed 3 times with PBS and incubated with 0.3-0.5mg/ml EZ-Link Sulfo-NHS-
LC-Biotin (Pierce) for 30 min at 4°C. 100mM Glycine/PBS2+ were used to quench for 5 
min. Cells were lysed with 1ml of  RIPA buffer supplemented with protease inhibitor 
cocktails (Roche) at 4°C for 10 min. Supernatants were incubated with agarose/PBS for 4 
hours at 4°C before addition of streptavidin agarose. The samples (Streptavidin-Biotin 
lysates) were incubated overnight at 4°C. After two washes with RIPA buffer, the 
samples were boiled for 5 min in 2x Laemli sample buffer. The samples were then 
separated on a 10% SDS-PAGE gel and analysed by Western blotting.  
 
5.2.4.7: Secretion assays 
5.2.4.7.1: Bulk secretion assay 
Cells were starved in Met/Cys free media for 30 min and then pulse labeled with 
30µCi of [35S]-Met/Cys (S35-EXPRESS from Amersham) per well of a 6-well plate for 
10 min at 37˚C. Incorporation of  radioactivity into proteins was stopped by placing the 
cultures on ice and by 3 washes with ice-cold full DMEM (with Met/Cys plus spacing 
serum). Subsequently the cells were shifted to 18°C for 3 hours, washed with 
5%BSA/PBS2+ followed by 2 washes with PBS2+ then shifted back to 37°C. To 
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determine the kinetics of secretion, culture supernatants were collected at different times. 
[35S]-labeled proteins were precipitated by 10% TCA, collected on filters (GF/C filters, 
Whatman) and quantified by scintillation counting. To determine total incorporation of 
[35S]-Met/Cys into cellular proteins, the cells were lysed in RIPA buffer supplemented 
with protease inhibitor (Roche) for 10 min. Supernatants were collected, TCA treated and 
processed as above. For controls, cells remained incubated on ice before supernatants 
were collected and cells were lysed and analysed. 
 
5.2.4.7.2: [35S]-Met/Cys pulse-chase and cell surface biotinylation of MHC-I 
molecules 
Cells were starved in DMEM lacking Methione and Cystein for 30 min at 37°C. 
200µCi/ dish 35S-Met/Cys were added to cells and incubated for 15 min. After 3 washes 
with cold DMEM, cells were incubated at 18°C for 3 hours in DMEM supplemented with 
10mM Hepes to accumulate MHC-I molecules at the TGN. To start the chase, warm 
DMEM was added to each dish (except the 0 min dishes of control and knock-down cells) 
and incubated for 10 and 30 min. Cells were washed twice with PBS before lysis using 
RIPA supplemented with protease inhibitor cocktails (Roche). After preclearance using 
agarose beads, anti-MHC-I antibodies were added to lysates and incubated overnight at 
4°C and subsequently 1 hour with protein G agarose beads. The beads were washed twice 
in RIPA buffer before 100µl of denaturing buffer (2% Sodium Deoxycholate, 2% NP40, 
and 5% SDS in PBS). were added and boiled for 5 min. Ice-cold PBS was added to each 
sample and the lysates were transferred into new tubes for overnight incubation with 
Streptavidin beads. The samples were then washed twice with RIPA buffer and denatured 
in 2 x Laemli sample buffer for SDS-PAGE. The gel was stained and dried, and exposed 
to a phosphoimager. 
 
5.2.4.7.3: Staining and Fixing of SDS-PAGE gels 
SDS-PAGE gels were incubated with Coomassie brilliant blue staining solutions 
(25% isopropanol, 10% acetic acid [glacial] and Coomassie brilliant blue R250) for 30 
min at room temperature and destained in 10% acetic acid. The gels were then dried and 
exposed to a phosphoimager. 
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5.2.4.8: ImmunoGold EM (in collaboration with Prof. Dr. Judith Klumperman’s lab) 
5.2.4.8.1: Sample preparation for Immunogold labeling and electronmicroscopy 
Hela cells were plated in 10cm-dishes in 75-90% confluency one day before 
transfections. Single or double transfections were performed using Lipofectamine/Plus 
reagents. Cells were transfected either with only GFP-hSac1 construct or together with 
Fapp1-PH-RFP-Myc. For double-staining of hSAC1 and OCRL1, hSAC1-
pCMV3TagMyc and GFP-OCRL1 constructs were used. Cells were fixed 24 hours post-
transfections using either fixation protocol A or B as follows: 
 
Fixation protocol A: 
Cells in 10ml of culture medium were fixed by gently adding 10ml of 4% 
paraformaldehyde  (diluted from 10% paraformaldehyde in ddH2O) and incubated for 10 
min at RT. The fixative-medium in dishes was replaced by 4% paraformaldehyde diluted 
in 0.1M phosphate buffer. Samples were stored at 4˚C before they were sent for 
immunogold labeling. 
 
Fixation protocol B: 
An equal volume of Fixative A3 (4% paraformaldehyde, 0.4% Glutaraldehyde in H2O) 
was added to cells containing cell culture medium. Fixation with Fixative A3 was done at 
RT for 10 min and Fixative B was added to cells for either 2 hours at RT or overnight at 
4˚C. After rinsing fixed cells with 0.1M Phosphate buffer, 1% paraformaldehyde in 0.1M 
phosphate buffer, pH7.4 were added to cells and samples were stored at 4˚C. 
The individual dishes were filled with appropriate fixatives, sealed well using parafilm 
and covered with plastic foam bags before sending out to Prof. Dr. Judith Klumperman’s 
lab. 
 
5.2.4.9: Apoptosis tests in Hela cells treated with hSAC1 siRNAs 
(a) DAPI staining 
Hela cells treated with hSAC1 siRNA or control RNA were fixed with 4% 
formaldehyde and stained with 1µg/ml DAPI solution in the dark for 30min after 3 
washes with PBS. Cells were mounted and viewed under a fluorescence microscope. 
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(b) PARP cleavage and WB 
hSAC1-depleted cells or control cells were washed 3 times in PBS, trypsinized and 
cell suspensions were collected in eppendorf tubes. After 2 min centrifugation at 2 x 
1000g rpm, cell pellets were collected and lysed in 2 x Laemli sample buffer (LSB). 
Lysed cells in LSB were boiled for 5 min and the supernatants were loaded on a SDS-
PAGE gel after 5 min centrifugation at 14 x 1000g to removed cell debris. To check 
for PARP cleavage, a specific PARP antibody was used to detect PARP on a WB. 
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